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ABSTRACT

MOLECULAR CLONING AND ANALYSIS OF THE PROMOTER FOR RAT
HEPATIC NEUTRAL CHOLESTEROL ESTER HYDROLASE
By Ramesh Natarajan, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at V irginia Commonwealth University.
V irginia Commonwealth University, 1 997.
Major Director: W. McLean Grogan, Professor, Department of B iochemistry and
Molecular B iophysics

Neutral cholesterol ester hydrolase (CEH) is a key enzyme in regulating hepatic
free cholesterol. Using the CEH specific eDNA sequence in the 5' -untranslated region as
a primer, 1 . 3 kb of sequence upstream of the ATG init iation codon was ampl ified and
cloned.

Primer extension analysis with total RNA from rat primary hepatocytes

identified a transcription init iation site, 60 bases upstream from the init iation codon. No
typical TATA-box sequences were found upstream from the transcription start site.
However, a consensus GC-box, which can bind the positive transcription factor SP I, was
found 35 bases upstream from the transcription start site. In addit ion the promoter also
contained several hormone responsive half elements, sterol response elements, ubiquitous
transcription factor binding sites and liver specific elements.

X

To determine the promoter activity of the rat CEH gene, the 1 .3 kb of 5' -flanking
region was fu sed to a luciferase reporter gene.

Smaller 5' -deletion constructs were

obtained by generation of unidirectional nested deletion breakpoints in the fu ll-length
construct with Exonuclease III.

Basal promoter activity, as well as transcriptional

regulation by hormones, signal transduction pathways and agents perturbing cholesterol
metabolism were studied in human hepatoblastoma HepG2 cells and cultured primary rat
hepatocytes by transient transfection assays of the promoter activity of the deletion
constructs.

Functional glucocorticoid response elements, phorbol ester responsive

sequences and sterol responsive sequences were mapped with both the culture systems.
Results indicate that the first 599 base pairs upstream of the initiation codon and the
region between nucleotides - 1 3 1 7 and - 1 1 90 regulate the effects of various physiological
stimuli.

The effects of various stimuli used in this study were similar in the two cell

lines. The rat CEH gene appears to be finely regulated by distinct signals converging to
consensus promoter regulatory sequences.

INTRODUCTION

Cholesterol ester hydrolases (CEH) are a family of ubiquitous enzymes that are
found in many organisms.

In mammals they occur in many tissues and are associated

w ith different functions, depending on location. They have been found in liver (Deykin
and Goodman , 1 962) , pancreas (Calame et al, 1 975), adrenals (Trzeciak and B oyd ,
1 974 ) , testis (Durham and Grogan, 1 982), intestine (Gallo et al, 1 980), mammary glands
(Martinez and Botham, 1 990) , placenta (Chin and Morin , 1 97 1 ), brain (Eto and Suzuki,
1 972), adipose tissue (Pittman et al, 1 975), macrophages (Small et al, 1 989), artery
(Hajjar et al, 1 983) and corpus luteum (Cook et al, 1 983), where they catalyze the release
of free cholesterol and fatty acids from cho lesteryl esters, an intracellular storage form o f
cholesterol. Mult ip le forms o f CEH have been reported i n testis (Durham and Grogan ,
1 984) , brain (Eto and Suzuki, 1 972), adrenals (Pittman and Steinberg, 1 977) and l iver
(Deykin and Goodman, 1 962; Nilsson, 1 976). They have been identified in different sub
cellular organelles including cytosol (Deykin and Goodman, 1 962), lysosomes (Lundberg
et al, 1 990), endoplasmic reticulum (Gandarias et al, 1 987), mitochondria (Deykin and
Goodman, 1 962) and nuclei (Deykin and Goodman, 1 962).

Whi le the pancreatic and

intestinal CEH ' s have a digestive role, the CEH in adipose tissues and steroidogenic
organs provide substrate for steroidogenesis.

The lysosomal CEH on the other hand

hydrolyses cholesteryl and glyceryl esters during lipoprotein degradation. Although rat

2
liver contains both lysosomal and microsomal CEH activities, the major hydrolytic
activity is associated with a unique cytosolic cho lesterol ester hydrolase that is
appropriately located, rationally regulated and is capable of mobilizing free cho lesterol
from cho lesteryl ester stores (Natarajan et al, l 996a) .

However, because most of the

research to date has focussed on the bile salt-stimulated cho lesterol esterase found
initially in the pancreas and the hormone sensitive l ipase I cho lesterol esterase found in
steroidogenic t issues, I will briefly review these enzymes prior to discussing the
properties of the hepatic cytosolic CEH .
Bile salt-stimulated cholesterol esterase
The bile salt stimu lated cholesterol esterase has been purified fro m many different
sources including rat and human pancreatic juice (Gallo, 1 98 1 ; Lombardo et al, 1 978),
pancreas from different species (Wang, 1 988; Jacobson et al, 1 990; Rudd et al, 1 987), rat
liver (Camu l l i et al, 1 989) and human milk (Rudd and Brockman, 1 984; Wang and
Hartsuck, 1 993) .

This enzyme has a broad substrate specificity.

In addition to the

hydrolysis of cho lesteryl esters, the enzyme is capable of hydrolyzing mono-, di-, and
triacylglycerol, phospholipids, and esters of fat-soluble vitamins.

Enzyme activity

against these substrates can be activated several fo ld by bile salt, with the trihydroxylated
bile salts being more potent than their dihydroxylated counterparts (Hernell and
Olivecrona, 1 974; B lackberg and Hernell, 1 993) .

This enzyme can also hydrolyze

lysophospholipid (Han et al, 1 987). However, this activity is bile salt-independent. The
bile salt-stimulated cholesterol esterase has also been demonstrated to have lipoamidase
act ivity (Hui et al, 1 993). Han et al were the first to report the primary sequence of this
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protein, based on isolation and cloning o f a 2 kb full-length transcript from rat pancreas.
Hui et al used an independent approach, based on immunoreactivity, partial protein
sequencing , and cloning of the eDNA to confirm identity between the pancreatic
lysophopholipase and cho lesterol esterase.

The sequence o f bile salt-stimulated lipase

found in milk was also shown to be identical to the pancreatic cholesterol esterase (Hui
and Kissel, 1 990; N ilsson et al, 1 990) , thereby establishing the identity between these
proteins.

The cholesterol esterase sequence displays a high degree of homo logy with

other serine esterases, such as acetylcholinesterase and cholinesterase.

These proteins

contain the catalytic triad serine-histidine-acidic residue at simjlar locations o f the
protein.
The complete sequence of the bile salt-stimulated cholesterol esterase gene has
been determined in the rat (Fontaine et al, 1 99 1 ), and partial sequences with intron-exon
junctions have been reported for both the human and the mouse cho lesterol esterase gene
(Lidmer et al, 1 99 5 ; Lidberg et al, 1 992). Both the rat and the mouse cholesterol esterase
genes are single copy genes in their respective genomes , spanning approximately 7 kb.
The human gene is approximately 9 kb in length, and is present in the human genome
along with a cholesterol esterase- like gene.

The 5' flanking region of the cho lesterol

esterase gene shares several homologous domains with that of the pancreatic lipase gene
(Mickel et al, 1 989). There are 5 distinct sequences each spanning at least I 0 residues,
that are similar between the cholesterol esterase and pancreatic lipase genes. S ince the
pancreatic l ipase has a key role in dietary lipid absorption, it has been suggested that the
cholesterol esterase synthesized by the pancreas may be involved in a similar process.
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The 5' flanking region also contains consensus sequences for pancreas specific enhancer
elements (Fontaine et al, 199 1 ; Lidberg et al, 1 992), a tissue-specific mammary g land
factor recognition sequence (Lidberg et al, 1 992) and an I I bp conserved sequence
present in a number of milk protein genes (Lidberg et al, 1 992) such as lactalbumin and
casein.

This consensus sequence may be responsible for cho lesterol esterase gene

expression in lactating mammary g lands.
In addition to transcriptional regulation, cholesterol esterase biosynthesis is also
regulated post-transcript ional ly in response to gastric hormones like cholecystokinin,
secretin and bombesin.

The hormone-induced cholesterol esterase biosynthesis is not

dependent on de novo RNA synthesis and does not alter the level of cho lesterol esterase
mRNA ( Huang and Hui, 1 99 1 ) .

Instead hormonal treatment increases translational

efficiency of the cho lesterol esterase mRNA. The hormone-induced cholesterol esterase
biosynthesis is mediated via calcium mobilization and protein kinase C-dependent
mechanisms (Brodt-Eppley and Hui, 1 995).
Disruption of the cho lesterol esterase gene

m

knockout experiments

abo lished cholesterol esterase activity in the intestinal tract. However, while cholesterol
absorption efficiency

was

unaffected,

the

absorption of cho lesteryl

esters

was

dramatical ly decreased in the cho lesterol esterase knockout mice (Howles et al, 1 996),
suggesting that cholesterol esterase is not involved in the cho lesterol absorption process
but is only important for the absorption of substrates with carboxy lester bonds.
Hormone sensitive lipase
Hormone sensitive l ipase (HSL) is another enzyme with high cho lesterol esterase

5
activity. Although this protein was originally isolated based on its abi lity to hydrolyze
triglyceride, subsequent characterizat ion of the protein revealed its abi lity to hydrolyze
cho lesteryl esters w ith equal e fficiency.

The HSL is most abundant in adipose tissue,

heart, skeletal muscle and in steroidogenic tissues such as the adrenals, ovary and testes.
In contrast to the bile salt-stimulated cholesterol esterase, which requires direct
interaction of the bile salt with the enzyme for activation, bile salt is not a required
cofactor for HSL.
The primary structure of HSL was deduced by cloning and sequencing of the
eDNA, from both rat and human adipose tissue (Holm et al, 1 988; Lombardo et al,
1993). The HSL contains within its sequence the GXSXG motif, a characteristic of other
serine esterases and lipases. However, the histidine and acidic amino-acid residue in the
catalyt ic triad have yet to be identified.
As the name impl ies, the HSL hydrolytic activity is stimulated by l ipolyt ic
hormones such as catecholamines. The mechanism o f action is through cAMP-dependent
protein kinase-mediated phosphorylation of a serine residue (Holm et al, 1 988).

In

contrast, the inactivation o f the HSL by anti-lipolytic hormones, such as insu lin, is
indirect through lowering of the cAMP level by a cAMP phosphodiesterase.
The HSL gene spans approximately I 0 kb and contains 9 exons (Lang in et al,
1 993).

The intron-exon organization of the HSL gene resembles that of the bile salt-

stimulated cho lesterol esterase, with each exon encoding a key functional domain of the
protein.

The 5' flanking region of the mouse HSL gene has adipose tissue speci fic

elements (Rice et al, 1 990) and an element responsible for protamine I gene expression

6
m

the testes (Tamura et al, 1992).

The presence o f the consensus sequences in the

regulatory region of the HSL gene is consistent with its expression

m

these t issues.

Consensus sequences for Ets- 1 and Pu. I are also present, suggesting that these may
represent cis-acting elements responsible for monocyte/macrophage expression o f this
gene ( Kiemsz et al, 1 990).

In addition, a preadipocyte repressor element (Swick and

Lane, 1992) and sterol regulatory element- ! sequences (Goldstein and B rown, 1 990) are
also present.
Although HSL activity I immunoreactivity was originally found in the adipose
tissue, it has been shown to be present in the heart, skeletal muscle, adrenals, ovaries,
p lacenta and in some macrophage cell lines ( Kraemer et al, 1 993). It has been proposed
that the HSL in adipose tissue, skeletal muscle and heart serves as a triacylglycerol lipase
in supp ly ing fatty acids to these tissues.

On the other hand, its role in ovaries and

adrenals may be related to its cholesteryl ester hydrolytic activity and it possibly
mobilizes cholesteryl ester stores for steroid biosynthesis. HSL is also found in the testes
where it is expressed in a stage-dependent manner, coinciding w ith the onset o f
spermatogenesis. Testicular expression o f the gene was localized t o Sertol i cells instead
o f the Leydig cells (Holst et al, 1994), suggesting that the role o f this protein in the testis
is most likely related to mobilization of lipid droplets in Sertoli cells rather than for
steroid biosynthesis in Leydig cells.

As mentioned be fore, the HSL is also found in

several mouse macrophage cell l ines.

The functional signi ficance for macrophage

expression o f the HSL is speculated to be the hydrolysis o f cho lesteryl esters liberating
free cholesterol for e fflux from the cells (Khoo et al, 1 98 1; S mall et al, 1 989). Based on
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these observations, the importance of this enzyme tn dictating macrophage foam cell
formation and in athergenesis has been postulated.
Cytosolic Cholesterol Ester Hydrolase : Isolation and cloning
The cytosolic CEH represents the major regulated cho lesterol ester hydrolytic
activity in rat liver. Conventional protein purification procedures have been used in this
laboratory to purify this hepatic CEH from rat livers (Ghosh and Grogan, 1 99 1). The
enzyme was purified 1 2,600 - fo ld by ammonium sulfate precipitation, cation exchange
chromatography and gel permeat ion high pressure l iquid chromatography w ith an overall
yield of 20%. The identity of this enzyme has been a controversy for over a decade.
Gallo et al first suggested that hepatic CEH is different from the pancreatic CEH, by
showing that antibodies to pancreatic CEH did not cross react with hepatic CEH.

But

Harrison et al reported that the anti-pancreatic CEH antibodies (supplied by Gallo) could
inhibit 72% of hepatic CEH activity and therefore suggested identity between these
enzymes. Camul l i et al isolated a liver protein using anti-pancreatic CEH antibodies on
an antibody affinity column.
hepatic CEH.

However this protein had properties different from the

Kissel et al then cloned the eDNA for rat pancreatic CEH and

demonstrated the presence of corresponding RNA in rat liver. However the CEH purified
by Ghosh and Grogan ( 199 1 ) differs from the pancreatic CEH in several ways.

This

hepatic CEH has orders of magnitude greater total activity than pancreatic CEH, is
protein kinase A activated, is bile salt independent and has no cross reactivity w ith ant ipancreatic CEH antibodies.

Also a specific neutralizing antibody to hepatic CEH

generated in this laboratory cross reacted only weakly w ith pancreatic CEH on Western
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blots (Ghosh and Grogan , 1992). More recently a 1 923 bp eDNA for rat hepatic CEH
was cloned by screening a rat liver lambda gt I I eDNA l ibrary with an end-labelled
synthetic o ligonucleotide derived from the conserved active site sequence of rat and
human pancreatic cholesterol esterase and human milk bile salt stimulated lipase (Ghosh
et al, 1995). This eDNA hybridized to a single strong 2.3 kb band on Northern blots o f
rat liver mRNA and included an open reading frame coding for 565 amino acids,
corresponding to a protein of molecular weight 62 143 (unglycosylated), consistent with
the 66 kDa mobility of rat liver CEH on SDS-PAGE. The eDNA sequence for hepatic
CEH has only 44% homo logy with pancreatic CEH , whereas the predicted amino acid
sequence has only 3 1 % identity.

The identity of the eDNA obtained with the puri fied

CEH was demonstrated by immunoreactivity of ant ibodies to hepatic CEH with the
fusion protein produced by the recombinant phage and w ith protein expressed in a
prokaryotic expression system, and also by production o f h igh levels o f hepatic CEH
activity and a 66 kDa immunoreactive protein in COS cells trans fected with an
expression vector containing the fu ll-length eDNA (Ghosh et al, 1995).
Characterization of hepatic cytosolic CEH
The purified hepatic CEH exhibited activity over the pH range 5.0 - 9.0 with
optimal activity at pH 7.0 to 7.5 (Ghosh and Grogan, 199 1 ). The purified enzyme eluted
as a single peak from a FPLC chromatofocussing column corresponding to a pi value o f
5.5 (Ghosh and Grogan , 1 99 1).

As mentioned earlier, hepatic CEH i s activated by

cAMP-dependent protein kinase (PKA) and also by ci+- phospholipid dependent protein
kinase (PKC).

Thus, CEH is regulated by reversible phosphorylation, with the
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phosphorylated form being the more active form (Ghosh and Grogan, 1 989). Whereas
the cytosolic enzyme is bile salt independent, the purified enzyme is activated by
increasing taurocholate concentrations up to I mM. The activation remained more or less
constant up to I 0 mM and then declined with further increases in concentration (Ghosh
and Grogan, 1 99 1 ).

Purified hepatic CEH is strongly inhibited by 20 - 40 mM

taurocholate in marked contrast to the pancreatic CEH which is known to be activated by
bile salts in this concentration range. While the purified CEH requires a minimal level of
taurocholate (0.25 mM) to prevent aggregation of the enzyme to an inactive state, bile
salts can also modify the physical state of the substrate. The purified enzyme hydrolyzes
oleoyl esters of both cholesterol and glycerol, although the activity was consistently
higher with cholesteryl o leate than w ith triolein at all taurocholate concentrations
(Natarajan, et al, 1 996a). With cholesteryl oleate as a substrate, enzyme activity rap idly
increased between 2.5 - 6.5 f..iM and gradually increased thereafter with further increases
up to 300 f..iM .

Thus, typical of enzymes with insoluble substrates, this CEH did not

saturate with substrate within the range of feasible substrate concentrations. The activity
2
2
2
of purified CEH is also independent of divalent metal ions like Zn + , Cu+ and Cd+ .
However these cations were mildly inhibitory at one or more concentrations from I 1 000 f..iM (Natarajan et al, 1 996a).
CEH belongs to the family of serine esterases which are characterized by the
presence of a conserved catalytic triad (serine, histidine and an acidic residue). Simi lar to
other cholesterol esterases, purified CEH was inhibited by phenylmethylsulfonylfluoride
(PMSF), with 50% inhibition at 0. 1 mM PMSF (Natarajan et al, 1 996a).

This is
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consistent with the identification o f the consensus serine esterase active site.

The

sulfhydryl specific agent mercury benzoate, inhibited the enzyme activity 30% at 3 mM
(Natarajan et al, 1 996a). Inasmuch as iodoacetamide and N-ethylmaleimide affected a
modest activation, inhibition by Hg+

2

probably reflects a general effect of divalent

cations, rather than an interaction with an essential sulfhydryl group.

Since CEH

2
2
catalyzes the hydro lysis of uncharged esters and is inh ibited by Cu + and Hg + , but not by
iodoacetamide, it has the properties of a class A esterase, as described by Aldridge, 1 95 3 .
In addition t o its abi lity t o hydrolyze physiologically relevant substrates like cho lesteryl
oleate and triolein, this cytosolic CEH can also hydrolyze paranitrophenyl (PNP)- esters
of fatty acids. While esterases like lipoprotein lipase and pancreatic CEH can efficiently
hydrolyze the water soluble substrate PNP-acetate, hepatic CEH demonstrated the lowest
activity towards this substrate.

Activity increased with chain length, peaked with the

more lipophilic PNP-caprylate and then declined gradually with increasing chain length >
C8 (Natarajan et al, 1 996a) . However hydrolytic act ivity was consistently higher with the
more lipophilic esters than with PNP-acetate.
Serine esterases such as lipoprotein lipases and hepatic lipase have highly variable
trypsin- labile loop structures formed by disulfide bridges, which confer substrate binding
specificity. Trypsin cleavage at a specific site in this loop abolishes lipoprotein lipase
activity with triolein but not with more hydrophilic tributyrin. Mild trypsin digestion of
the purified CEH results in progressive and selective loss of activity with cho lesteryl
oleate and triolein, but not with more hydrophi l ic PNP-caprylate.

Analysis of CEH by

SDS-PAGE after 24 hrs. of trypsin digestion revealed only a single band at 66 kDa,

II
indistinguishable from the mobility of the unmodified protein (Natarajan et al, 1 996a).
By analogy with l ipoprotein l ipase, this is consistent with the cleavage of a single peptide
bond within a loop domain which confers substrate specificity on CEH.

Analysis of

secondary structure for CEH by the GCG program (PEPTIDESTRUCTURE) , using
algorithms for hydrophilicity ( Kyte-Doolittle),

surface probabilit y (Emini), chain

flexibility ( Karplus-Schulz) and secondary structure (Chou-Fasman and Garnier
8
Osguthorpe-Robson), predicts such a loop between Cys 7 and Cys116 , containing a highly
exposed trypsin cleavage site at Arg

104

. This site has a high hydrophilicity index (2.4), a

high surface probability ( 5 . 8 ) and a predicted turn.
The hepatic cytosolic CEH is also developmentally regulated in the rat. In male
rats, age-related differences in mRNA, protein mass and catalytic activity suggest
transcriptional regulation and indicate an important role for CEH in cholesterol
homeostasis in the developing rat (Natarajan et al, 1 996). On the other hand, in female
rats it appears that hepatic CEH is subject to gender-specific mu ltivalent regulation by
post-translational mechanisms (Natarajan et al, 1 997).
Regulation of cholesterol homeostasis in the liver
As mentioned before, CEH releases free cholesterol from cholesteryl esters. Free
cho lesterol is an important structural component of cellular membranes. It has profound
effects on physical properties of membranes, as well as membrane associated activities
including enzymes and receptors invo lved in cho lesterol metabo lism and homeostasis
(Liscum and Underwood, 1 995). This free cholesterol is not evenly distributed among
the various membrane classes.

While plasma membranes are relatively rich in
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cholesterol, the endoplasmic reticulum has much lower cholesterol concentrations. The
mechanisms requ ired to maintain this gradient are not well understood as yet.
Hepatic free cho lesterol pools play important roles in the regulation of receptor
mediated uptake of cho lesterol, in the de novo biosynthesis of cholesterol, in bile acid
synthesis, in the esterification of free cholesterol and in the hydro lysis of stored
cho lesteryl esters.

Intracellu lar levels of free cholesterol are maintained relat ivel y

constant over a broad range o f metabolic states and cho lesterol fluxes through the liver
(Gould, 1 977; Klauda et al, 1 978; Erickson et al, 1 980).

While de novo cho lesterol

biosynthesis and uptake of dietary cholesterol as lipoproteins are the two input pathways
for cholesterol, conversion of hepatic cholesterol to bile acids and biliary secretion of
cho lesterol are the only significant output pathways (Fig. I). In response to cholesterol
influx or efflux, sterol balance in the hepatocyte is maintained by altering the flu x of
cho lesterol through I) endogenous cholesterol biosynthesis regulated by 3-hydroxy-3methylglutaryl-coenzyme A synthase (HMGCoAS) and the rate limit ing enzyme 3hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCoAR), 2) lipoprotein uptake,
synthesis and secretion which is part ly regulated by the low density lipoprotein (LDL)
receptor, 3) conversion of cho lesterol to bile acids which is regulated by sterol-27hydroxylase and the rate limiting enzyme cho lesterol-7a-hydroxylase (C7H) and 4)
reversible

conversion

of

excess

cho lesterol

to

cholesteryl

esters

by

acylcoenzymeA:cholesterol acyltransferase (ACAT) and hydrolysis of stored cholesteryl
esters to free cho lesterol by CEH .
Regulation of the LDL receptor and the other enzymes HMGCoAS, HMGCoAR,
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Figure I . Regulation of cho lesterol homeostasis in the rat liver. This figure shows the
input and output pathways involved in the regulation of cholesterol homeostasis in the rat
l iver as described in the text.
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C7H, stero l-27-hydroxylase and ACAT have been studied i n considerable detail.
HMGCoAS, HMGCoAR and the LDL receptor are actively regulated by transcriptional,
translational and post-translational modes (Goldstein and Brown,

1 990).

C7H is

primarily regulated at the transcriptional level (Spady and Cuthbert, 1 992) .

There is

some controversy regarding the ident ity of ACAT and its regulatory mechanisms are as
yet unclear. While a detailed explanation of the regulation of these enzymes is beyond
the scope of this dissertation, it is useful to review their regulation at the transcriptional
level.
The promoters for the LDL receptor (Osborne et al, 1 988), HMGCoAS ( S mith et
al, 1 98 8 ) and HMGCoAR (Dawson et al, 1 988) have been identified and characterized.
They are regulated through sterol regulatory elements (SRE- 1 ) in their promoters that
behave as conditional positive or conditional negative regulators of transcription when
bound by the sterol regulatory element binding protein (SREBP).
process are described in the follow ing section.

The details of this

The C7H promoter has also been

identified and characterized (Jelinek and Russell, 1 990; N ishimoto et al, 1 99 1 ; Chiang et
al, 1 992). No SRE ' s have yet been found in the C7H promoter.

However the gene is

regulated by different physiological stimuli including bile acids, hormones and signal
transducing agents (Crestani et al, 1 994; Chiang and Stroup, 1 994; Crestani et al, 1 995).
While an ACAT eDNA has recently been identified, no information is available on its
promoter (Chang et al, 1 993).
Another common mode of regulation is the short-term regulation of HMGCoAR,
C7H, ACAT and CEH by reversible phosphorylation. In contrast to HMGCoAR which
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is inhibited by phosphorylation and activated by dephosphorylation, the activities of C7H
and ACAT are increased by in vitro phosphorylation (Gavey et al, 1 983; Goodwin et al,
1 982; Beg et al, 1 987).

As mentioned before, CEH is also regulated by reversible

phosphorylation and the phosphorylated form is the active form.

Based on these

observations there appears to be a coordinated control of the enzymes involved in
regulation of cholesterol homeostasis in the l iver by reversible phosphorylation. Under
conditions of increased phosphorylation in the cell, HMGCoAR would be inh ibited and
the free cholesterol pools would be depleted due to increased activit ies of ACAT and
C7H. CEH, which is more active in the phosphorylated state, would then be important in
maintaining the free cho lesterol level in the cell.

However, a mechanism by which

cellular cholesterol levels might affect the phosphorylation status of the various enzymes
has not been demonstrated.
Unl ike free cho lesterol, the levels of intracellular cholesteryl esters vary greatly
with rates of influx and efflux of cho lesterol from the liver.

They serve as an inert

storage pool that is capable of absorbing considerable amounts of cholesterol. Since the
physical properties of cholesteryl esters are not conducive to the formation of membrane
bi layers, their concentration in membranes is very low.

Therefore, most cholesteryl

esters are incorporated into lipoproteins or triglyceride rich cytoplasmic droplets. These
cytoplasmic droplets serve as substrates for CEH and provide a reservoir for mobil ization
of cholesteryl ester stores.
Promoters and control of gene expression
The DNA of a cell has information responsible for the maintenance of that cell
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and ult imately the entire organism.

Genetic information is first transcribed by RNA

polymerase and then translated into the finished protein product. Cells have developed
complex systems to regulate these processes at every step. Transcription initiation is a
complex process involving both protein:DNA and protein:protein interactions. While the
details of transcription initiation from mRNA encoding genes by RNA polymerase II and
associated factors are beyond the scope of this dissertation, it should suffice to ment ion
some of the essential features of this process. Eukaryotic promoters generally consist of
cis-acting elements close to the transcription initiation site, which help to direct gene
expression.

Many promoters contain a TATA-box (consensus sequence TATANA;

where N indicates a position that can be occupied by any nucleotide) approximately 30
bases upstream of the transcription initiation site, which is recognized by the multi
subunit complex TFIID.

Interaction of TFIID with other init iation factors correctly

positions RNA polymerase on the DNA and allows transcription to proceed.
Another common promoter element called the CAAT -box (consensus sequence
CCAAT) is found between -80 and -60 nucleotides upstream of the transcription
in itiation site for RNA polymerase II. Although not palindromic, this sequence occurs
naturally in both orientations and is bound by either the CTF/NF- 1 or CP I proteins
(Pearson et a!, 1 99 1 , Dutta et al, 1 990).
Transcription initiation also occurs from promoters that lack a TAT A-box and/or
a CAAT-box.

These promoters frequently contain another element whose consensus

sequence is GGGCGG. This sequence called the GC-box binds the positive transcription
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factor S P I .

It is functional in either orientation and can be present in one or multiple

copies.
In addition to these elements, eukaryotic promoters also contain other cis-acting
elements that bind different transcription factors and thus finely regulate the expression
of various genes. Some of the pertinent cis-acting elements and the transcription factors
that bind them are discussed below.
Glucocorticoid response element
Comparison

of

available

sequence

information

shows

the

consensus

glucocorticoid response element (GRE) to be (T/G)GTACAnnnTGTTCT (Beato, 1 989).
The GRE is a transcription enhancer because it functions through heterologous promoters
and in a relat ively position- and orientation-independent manner (Chandler et al, 1 98 3 ;
Yamamoto, 1 985).

A single GRE works when located immediately upstream of the

TAT A-box, but multiple copies are required when the GRE' s are located at a distance
(Strahle et al, 1 988).

There is considerable variation in the number and location of

GRE ' s . The long terminal repeat of the murine mammary tumor virus (MMTV) gene has
multiple GRE ' s clustered near the transcription initiation site (Payvar et al, 1 983). On
the other hand, the clustered GRE ' s of the tyrosine aminotransferase gene are located 2.5
kb fro m the transcription start site (Jantzen et al, 1 987). The rat phosphoenol pyruvate
carboxykinase (PEPCK) gene has a complex glucocorticoid response unit (GRU) that
spans I I 0 base pairs and inc ludes two glucocorticoid receptor binding elements
designated GR J and GR2 (lmai et al, 1 990), plus two accessory factor binding elements
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(AF I and AF2).

The rat C7H gene also has a similar GRU located 220 base pairs

upstream of the transcription start site (Crestani et al, 1 995).
The c lassical mechanism for glucocorticoid hormone action involves binding of
the hormone to a cytoplasmic form of the receptor, followed by a conformational change
("activation" or "transformation") that leads to its intranuclear translocation and binding
to chromatin. However the steroid-free glucocorticoid receptor binds specifically to the
GRE of M MTV in vitro. It is possible that upon binding of the hormone, the oligomeric
complex of glucocorticoid receptor and a 90 kDa heat shock protein dissociates, leaving
the DNA binding domain of the receptor free to bind to chromatin. One molecule of the
receptor binds to the TGTTCT half-site of the GRE, and a second molecule then binds to
the TGTACA half-site in a cooperative manner. The receptor contacts the DNA through
two zinc fingers in the DNA binding domain.

The amino-terminal finger interacts

specifically w ith one half of the GRE, whereas the carboxyl-terminal finger interacts with
the DNA helix flanking the GRE consensus sequence.

Transcription is enhanced,

presumably by bringing into close proximity the transactivation domain( s) of the receptor
with one or more components of the initiation complex.
Thyroid hormone response element
Unl ike the GRE, much less is known about the thyroid hormone response element
(TRE). The proposed consensus sequence for the TRE is TCAGGTCA---TGACCTGA
(Beato, 1 989). The "---" refers to gaps of I to 6 base pairs between the two half sites.
This consensus sequence contains half palindromes similar to the estrogen response
element but with different spac ing.
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Based on amino acid and structural simi larities, the thyroid hormone receptor
belongs to the class of steroid hormone receptors that regulate gene expression in a ligand
dependent manner. Similar to the glucocorticoid receptor, the thyroid hormone receptorDNA binding is mediated by a conserved sequence motif that is thought to form a tertiary
+2
structure of loops or "fingers" coordinated by a metal cation like zn .

Whi le thyroid

hormone can up regulate transcription through the TRE, it has also been demonstrated to
down regulate transcription of several genes including the thyroid-stimulating hormone
gene (Shupnik et al, 1 985). The thyroid hormone receptor can bind both TRE as well as
the c losely related estrogen response element. However, this binding does not result in
transcriptional activation. Instead it causes a decrease in the level of expression. Since
the consensus sequence of the TRE has centrally located gaps and the estrogen response
element is a variant of the TRE with a gap of 3 base pairs, the functional consequence of
thyroid hormone receptor binding to the estrogen response element is to decrease the
estrogen-dependent gene expression. Thus the presence or absence of a 3 base pair gap
in the DNA recognition sequence dictates positive or negative transcriptional control by
thyroid hormone.
Phorbol ester response element
S ince phorbol esters are activators of protein kinase C (PKC), before elaborating
on phorbol ester response sequences (PRS), I shall briefly discuss the role of
phosphorylation in the regulation of transcription.

Phosphorylation events are post-

translational modifications that affect the activity of various DNA binding proteins. They
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not only result in a conformational change in the protein but also affect electrostatic
interactions. There are three main levels of regulation by phosphorylation:
Transcription factors may be sequestered in the cytoplasm, bound to inhibitory
proteins. In response to various stimuli, the inhibitory protein is phosphorylated and this
causes dissociation of the transcription factor, which now enters the nucleus and binds
DNA to regulate transcription.

An example of this type of regulation is the

phosphorylation of the inhibitory protein IKB that causes it to dissociate from complexes
with other transcription factors, thereby enabling these transcription factors to enter the
nucleus and bind to chromatin (Hunter and Karin, 1 992).
Secondly, phosphorylation can also affect the binding activity of transcription
factors.

It can increase binding, as is observed with phosphorylation of the serum

response factor by casein

kinase II, or decrease

binding

activity as

seen

by

phosphorylation of c-Myb by the same casein kinase I I (Hunter and Karin, 1 992; Luscher
et al, 1 989).
Finally phosphorylation could affect transactivation events mediated by a
transcription factor.

For example, the cAMP responsive binding protein when

phosphorylated by protein kinase A in the activation domain leads to an increase in gene
expression driven by this element (Gonzalez and Montminy, 1 989).
Phosphorylation events are controlled by kinases, which in turn are controlled by
receptor initiated signals conveyed by multiple cell signalling pathways. While there are
several signalling mechanisms, this discussion will be l imited to the protein k inase C
(PKC) pathway, since phorbol esters are PKC activators. Activation of the PKC pathway
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is init iated by binding of ligand to receptor in the plasma membrane.

Generally the

receptor is thought to interact next with a specific heterotrimeric G protein (G q) which
requires bound GTP for activity.
subunit

to

dissociate

and

Association of the receptor with G q causes the a

interact

with

the

enzyme

phosphoinositide-specific

phospholipase C (PLCy) . PLC cleaves phosphoinositide 4,5-bisphosphate (PIP 2) which
is located in the inner leaflet of the plasma membrane, to generate inositol triphosphate
(IP3) and diacylglycerol (DAG).

Here, the pathway divides into two branches, each of

which is crit ical to the signal ling process. IP3. which is water soluble, diffuses into the
cytosol and causes the release of Ca+2 from the endoplasmic reticulum. This is mediated
2
by the binding of IP3 to special Ca+ channels in the endoplasmic membrane. The initial
rise in cytosolic calcium levels results in the movement of PKC from the cytosol to the
cytoplasmic

side

of

the

plasma

membrane.

Secondly,

DAG,

along

with

phosphotidylserine which is associated with the plasma membrane, can bind to PKC,
thereby increasing the affinity of the enzyme for calcium and resulting in enzyme
activation. While calcium ionophores mimic the affects of IP3, phorbol esters mimic the
affect of DAG. DAG can also be cleaved to produce arachidonic acid, which can either
be utilized for prostaglandin synthesis or other lipid signalling moieties. After activation
PKC phosphorylates cellu lar proteins on serine or threonine residues.

These proteins

may themselves further phosphorylate other cellular proteins leading to potentiation of
the signal.
The consensus PRS identified in many genes transcriptionally activated by
phorbol esters is TGACTCA (Deutsch et al, 1 988).

It is believed that 4�-phorbol- 1 2-
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myristate- 1 3-acetate

(PMA),

a

phorbol

ester,

affects

transcription

phosphorylation of transcription factors like NF-KB, c-Jun and c-Fos.

through

AP- I and AP-2

can also confer PMA responsiveness.
Sterol response element
Sterol response elements (SRE) are sequences found in the 5' -flanking region of
genes that respond to the levels of sterols in the cell. The consensus sequence for the
SRE is CACC(C/G)(Crf)AC (Smith et al, 1 988). This element enhances transcription in
sterol depleted cells and is inactivated when sterols accumulate in the cell.

In tissue

culture cells the most potent inactivators of SRE are oxysterols, which are derivatives of
cholesterol with additional hydroxy- or keto- groups that enhance their solubility. SRE is
also inactivated by cholesterol when it is delivered to cells in low density lipoproteins.
Two proteins designated sterol regulatory element binding proteins I and 2
(SREBP- l and 2) bind to SRE- 1 with a nucleotide specificity that precisely matches the
requ irement for sterol regulated transcription (Wang et al, 1 994). SREBP ' s are members
of the basic-helix-loop-helix-leucine zipper family of transcription factors. They bind to
DNA either as homodimers or as heterodimers. DNA binding is mediated by the basic
region and dimerization is mediated by the helix-loop-helix and leucine zipper structures.
The basic helix- loop-helix region is preceded by an acidic amino-terminal region which
is a putative transcription activation domain.
Three alternatively spl iced forms of SREBP- l have been identified ( Kawabe et al,
1 994). They are called SREBP- l a, SREB- l b and SREBP- J c . The three forms show no
functional difference in SRE- 1 binding or transcriptional activation in transfected cells.
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No alternative ly spliced forms of SREBP-2 have been identified as yet. SREBP- 1 a and
SREBP-2 differ from other basic helix- loop-helix zipper proteins in two important
aspects; firstly they are larger in size, and secondly they fail to recognize the palindromic
hexanucleotide sequences that are targets for all other basic helix-loop-helix zipper
proteins.

Instead they recognize the SRE- 1 sequence which contains a direct repeat of

CAC.
SREBP- 1 is synthesized as a 1 25 kDa precursor that is bound intrinsically to
membranes of the nuclear envelope and the endoplasmic reticulum.

In sterol depleted

cells, the precursor is cleaved proteolyt ical ly to generate amino-terminal fragments of
apparent mo lecular masses in the range of 66 kDa to 70 kDa that translocate to the
nucleus and bind to SRE- 1 . When cells are exposed to regulatory sterols, proteolysis of
the 1 25 kDa precursor form of SREBP- 1 is interrupted and the amount of the mature
nuclear form declines due to rapid turnover (Wang et al, 1 994) .
S RE- 1 sequences have been found in the 5 ' -flanking sequences of genes for the
LDL receptor (Osborne et al, 1 988), HMGCoAS (Yokoyama et al, 1 993), HMGCoAR
(Dawson et al, 1 988), farnesyl diphosphate synthase (Jackson et al, 1 995), squalene
synthase (Guan et al, 1 995), fatty acid synthase (Bennett et al, 1 99 1 ) and acetyl Co A
carboxylase ( Kawabe et al, 1 996; Lopez et al, 1 996). In addition to SRE- 1 sequences,
the promoters for the LDL receptor and HMGCoAR also have sequences that bind to
positive transcription factors. In the LDL receptor gene the major positive element is the
nuclear factor S P I (Sudhof et al, 1 987; Dawson et al, 1 988). The HMGCoAR promoter
contains mu ltiple binding sites for proteins in the nuclear factor- ! (NF- I ) family (Gil et
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al, 1 988). These positive e lements are required for the functioning of the SRE- 1 element.
In the LDL receptor and HMGCoAS promoters, the SRE- 1 acts as a conditional positive
e lement, enhancing transcription in the absence of sterols. In the HMGCoAR promoter
the SRE - 1 also acts as a conditional negative element, repressing transcription in the
presence of sterols.
Rationale for study
Cholesterol ester hydrolases are a group of ubiquitous enzymes that are present in
many tissues and are associated with different functions, depending on location. They
catalyze the release of free cholesterol and fatty acids from cho lesteryl esters, an
intracellular storage form of cho lesterol. The major cholesteryl ester hydrolytic act ivity
fou nd in rat liver is associated with a unique cytosolic CEH that is appropriately located,
rationally regulated and capable of mobilizing free cho lesterol from cholesteryl ester
stores.
Rat l iver cytosolic CEH has been purified to homogeneity. The eDNA for this
enzyme has been c loned and expressed.

The purified enzyme has been extensively

characterized biochemically and its physiological relevance has been well established. It
plays a crucial role in the regulation of hepatic levels of free and esterified cholesterol
along w ith HMGCoA reductase, cholesterol 7a-hydroxylase
A:cholesterol acyl transferase.

and acylcoenzyme

While HMGCoA reductase is actively regulated at the

transcriptional, translational and post-translational modes, cholesterol 7a-hydroxylase is
primarily regulated at the transcriptional level.

CEH has been demonstrated to be

regulated at the post-translational level by reversible phosphorylat ion.

Recently
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regulation at the transcriptional level was also studied by measuring the steady-state
mRNA levels under various conditions.
While most of the data reported to date suggest that CEH is regulated at the
transcriptional level, there is no direct evidence to support this mode of regu lation.
Therefore, isolation and characterization of the 5' -flanking portion of the CEH gene
would enable us to understand the regulation of this enzyme at the transcriptional level.
Specific objectives to be addressed are as follows:
I.

Using the sequence of the CEH eDNA, isolate and clone the 5 ' -flanking portion
of the CEH gene.

2.

Identify the transcription start site o f the CEH gene.

3.

Identify putative cis-acting elements regulating the expression of the CEH gene.

4.

Map regulatory regions in the 5' - flanking portion using reporter gene constructs
and transient transfection assays in human hepatoblastoma HepG2 cells and
cultured primary rat hepatocytes.

5.

Determine if the two culture systems used in this study have different effects on
the CEH promoter.

EXPERIMENTAL PROCEDURES

Isolation of the rat hepatic CEH promoter
The PromoterFinder DNA Walking Kit (Clontech) was used to isolate the rat
hepatic CEH promoter.

The kit contains five "libraries" of uncloned adaptor-ligated

genomic DNA fragments. The "libraries were prepared by digesting rat genomic DNA
with 5 different restriction enzymes that recognize a 6-base site and leave blunt ends, viz.
EcoR V, Sea I , Dra I, Pvu II and Ssp I .
PromoterFinder

adaptor,

the

unique

features

These fragments were ligated to a
of

which

el iminates

non-specific

amplification among the general population of DNA fragments. A combination of long
distance PCR, suppression PCR and "touchdown" PCR were then used isolate the 5 ' 
flanking portion o f the CEH gene.
The gene specific primer SEQP8 5 ' - TACCCCCAAGCTGTGCACGCAGCAAG
-3 ' , corresponding to positions 56 to 3 1 of the rat hepatic CEH eDNA and the anchor
primer AP I 5 ' -GTAATACGACTCACTATAGGGC-3 ' of the PromoterFinder kit were
used in a primary PCR with the five different "l ibraries" of genomic DNA as template.
Primary PCR was carried out in I X Tth PCR reaction buffer (Ciontech), 10 mM each
dNTP, 25 mM Mg(OAch, 10 11M adaptor primer AP I , 10 11 M gene specific primer
SEQP8, I 11 1 of Tth (2U/Ill)/ Vent polymerase (2U/!1 1)/Tth Start

™

Antibody (2.2 mg/11 l)

(Ciontech) mixture (20: I :5 ratio respectively) and I 111 of each genomic "library".
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°

°

Thermal cycling parameters were : 7 cycles of 94 C for 25 seconds and 72 C for 4 min,
°
°
3 2 cycles of 94 C for 25 seconds and 67 C for 4 minutes and then a 4 minute extension
°
at 67 C after the final cycle.
Primary PCR products were diluted I to 50. One 1-1 1 of the diluted products were
used as template in a secondary PCR with nested gene specific primer PAS3 5 ' GCGCATTGTGGAAGGAACAAATAGCCC- 3 ' , corresponding t o CEH eDNA specific
posit ions 6 to -2 1 in the 5 ' untranslated portion, and nested anchor primer AP2 5 ' ACT AT AGGGCACGCGTGGT - 3 ' . The secondary PCR was carried out i n a buffer of
the same composition as the primary PCR.

Thermal cycling conditions were also

identical to the primary PCR except that the number of cycles were reduced from 7 to 5
for the first step and from 32 to 20 for the second step.
The PCR products (5 1-1 I) were analyzed on a 0.6% agaroserrAE gel along with
DNA size markers in the form of a I kb ladder.

The secondary PCR products from

"l ibraries" 3 and 4 were T A-cloned into pGEMT -Easy vector (Promega) and sequenced
by the Dye Terminator Cycle Sequencing System.
Construction of rat CEH promoter/luciferase reporter genes
In order to clone the full length promoter into the luciferase reporter vector pGL3Basic

(Promega),

PCR

was

performed

with

the

primer

PAS5Bglll

5'-

gcaagatctGATGACAGAAAAGCTCTC - 3 ' (upper case letters indicate gene sequence),
bearing a Bgl II restriction site (underlined) and corresponding to position -37 upstream
of the init iation ATG codon, and anchor primer AP2 which has a Mlu I restriction site.
The 1 3 1 7 bp PCR product was then cloned into the Bgl 11-Miu I sites of pGL3-Basic to
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give p- 1 3 1 7Luc. The remaining constructs were obtained by generation of unidirectional
nested deletion breakpoints in p- 1 3 1 7Luc with Exonuclease III (Exo III) which can digest
DNA from one end at a uniform rate (Henikoff, 1 987). Briefly, p- 1 3 1 7Luc was cut with
Kpn I, to generate 3' overhangs resistant to Exo III digestion, and M lu I, to generate 5 '
overhangs susceptible t o digestion b y Exo III (Fig.2). The Kpn I-Miu I cut p- 1 3 1 7Luc
°
was then digested with Exo III at 30 C. Aliquots were removed at I minute intervals ,
fo llowed by digestion of single stranded ends with S I nuclease.

The ends were fil led

with KJenow fragment of DNA polymerase, religated with T4 DNA ligase and
transformed into TOP I OF' cells.
analysis and sequencing.

All plasmids were verified by restriction digestion

They were purified by double banding in cesium chloride

gradients or with Qiagen columns (Qiagen) as per manufacturers instructions.
Identification of transcription start site
Primer extension analysis was performed to identify the transcription start site.
The CEH eDNA specific primer PAS3 was radiolabelled in I X T4 polynucleotide kinase
32
buffer with 3 J.!l of [y- P] ATP (at 3000 Cilmmol, 1 0 mCi/ml) and I 11 1 of T4
°
polynucleotide kinase (8- 1 0 U/J.!I) at 37 C for I 0 min. The T4 polynuc leotide kinase was
°
then inactivated by heating to 90 C for 2 min. The radio labelled primer ( I pmol) was
annealed to rat liver total RNA ( 1 5 Jl g), prepared by cesium chloride density
centrifugation (Chirgwin et al), in I X AMY primer extension buffer ( 1 00 mM Tris-HCI,
pH 8.3, 1 00 mM KCI, 20 mM MgCh, 20 mM OTT, 2 mM each dNTP, I mM
spermidine) with 40

� sodium pyrophosphate at 58 °C for 20 min. The mixture was
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Figure2. Strategy for generation of 5 ' deletion constructs of rat CEH promoter!luciferase
reporter genes from p- 1 3 1 7Luc. The shaded region corresponds to the 1 3 1 7 bp 5 ' 
flank in g portion of the rat CEH gene cloned into pGL3-Basic. The fu l l-length construct
p- 1 3 1 7Luc was digested with Kpn I and Mlu I to generate 3' and 5 ' overhangs
°
respectively. The Kpn I-Mlu I cut p- 1 3 1 7Luc was digested with Exonuclease III at 30 C.
Aliquots were removed at I min intervals followed by treatment with S I nuclease,
Klenow fragment of DNA po lymerase and T4 DNA l igase as explained in Experimental
Procedures to obtain the 5' deletion constructs.
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allowed t o cool a t room temperature for 1 0 min. The primer was then extended b y AM Y
°
reverse transcriptase ( 1 . 3 U) for 30 min. at 42 C.

Primer extension products were

analyzed on an 8% denaturing po lyacrylamide gel fol lowed by autoradiography for 1 6
hrs.

Radiolabelled standards were used to determine the size of the primer extension

products.
Culture of human hepatoblastoma HepG2 cells
2
Human hepatoblastoma HepG2 cells were grown in 75 cm tissue culture flasks in
Minimal Essential Medium containing L-glutamine (0.292 mg/ml), non-essential amino
acids ( I X), sodium pyruvate (0. 1 1 mg/ml), penicillin ( 1 00 U/ml), streptomycin ( 1 00
°
Jlglml) and 1 0% heat inactivated fetal bovine serum at 37 C in a humidified incubator in
the presence of 5 % C02 . Cells were seeded in 35 mm dishes w ith 2 ml of medium and
grown to confluence.

Medium was changed every two days until the cells were

confluent. These cells were then used for transient transfect ion analysis.
Isolation and culture of primary rat hepatocytes
Primary rat hepatocytes used in this study were kindly provided by Dr. P. B .
Hylemon (Dept. o f M icrobiology, MCVJVCU).

Hepatocytes were isolated from male

Sprague-Dawley rats (250-300 g) using the collagenase perfusion technique of B issel and
Guzelian ( 1 980).
blue exclusion.

Prior to plating, cells were judged to be > 90% viable using Trypan
5
Parenchymal cells (8. 5x l 0 ) were plated in 1 . 5 ml of Will iam' s E

medium containing L-thyroxine ( I J.1 M), dexamethasone (50 nM), penic il lin ( I 00 U/ml)
°
and 1 0% fetal calf serum in 35 mm Primaria culture dishes (Falcon) at 37 C in a 5% C02
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atmosphere.

After a 6 hr. attachment period, the hepatocytes were used for transient

transfect ion analysis.
Transient transfections
B oth HepG2 cells and the primary rat hepatocytes were transiently transfected by
the calcium-phosphate DNA coprecipitation technique (Graham and van der Eb, 1 973)
with the MBS mammalian transfect ion kit (Stratagene).

Specifically, 2.0 f.l g of test

plasmid and 0.5 f.l g of pCMVB, an internal standard for the normalization of transfection
efficiency, were incubated at room temperature for I 0-20 min. with CaCb (0. 1 25 mM)
and BBS (N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid and buffered saline, pH
6.95). Culture medium in the dishes were replaced with 2 ml of fresh medium containing
6% modified bovine serum instead of 1 0% fetal calf serum. Fo llowing addition of DNA
°
suspension, cells were incubated for 3 hrs at 35 C under 3% C02 .

They were then

washed three times w ith phosphate-buffered saline (PBS) and refed with appropriate
serum-free medium with the indicated concentration of agent or vehicle. Dexamethasone
was reconstituted in 1 00% ethanol. L-thyroxine was dissolved in a solution containing
°
70% ethanol and 1 5 % 6N NaOH. The solution was vortexed well and kept in a 37 C
water bath for I 0 min . . Fetal calf serum ( 1 5 %) was then added prior to use. PMA was
reconstituted in I 00% DMSO.

Mevalonolactone and squalestatin were reconstituted in

water. Squalestatin was kindly provided by Glaxo Research Group, Middlesex, United
Kingdom, UB6 OHE.

Media containing dexamethasone, L-thyroxine and PMA were

°
replaced after 20 hrs . . Transfected cells were incubated at 37 C under 5% C02 for
different periods of time as indicated in the figure legends.
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Reporter enzyme assays
After the incubation period, both HepG2 cells and primary rat hepatocytes were
washed twice w ith PBS , lysed and harvested with 200-300 11 1 of reporter lysis buffer as
per manufacturers instructions (Promega).

Luciferase activity was assayed by mixing

room temperature luc iferase assay reagent ( 1 00 fl l) to cell extracts (5-20 fl l) also at room
temperature in a luminometer (Lumat LB950 1 , Berthold) (Wood, 1 99 1 ) and measuring
total light emission during the initial 20 seconds of the reaction. Luciferase act ivity was
calculated as relative light units (RLU) per mg of protein. B-galactosidase activity was
measured in 50- 1 00 11 1 of lysate using o-nitrophenyl B-D-galactopyranoside as substrate
(Nielsen et al, 1 983). The product was detected by measuring the absorbance at 420 nm
in a spectrophotometer.

B-galactosidase activity was expressed as units (nmols of o

nitrophenoVmin./mg protein). Protein concentrations were determined using the Pierce
BCA reagent (Smith et al, 1 985).

Luciferase activity was normalized, for inter-assay

variabilit ies due to transfection efficiency and extract collection, by dividing the
luciferase activity by the B-galactosidase activity.
Statistical analysis
Data was analyzed for statisticall y significant differences by Student ' s t-test and
p<O.O I was considered significant.

RESULTS

Cloning of the rat CEH promoter
In order to isolate the promoter for the rat CEH gene, we used the PromoterFinder
DNA Walking Kit (Ciontech).

This kit contains five "libraries" of uncloned adaptor

l igated rat genomic DNA fragments. A combination of long-distance PCR, suppression
PCR and "touchdown" PCR were used to isolate the 5"-flanking portion of the CEH
gene.

The primary PCR with primers SEQP8 and AP I (see experimental procedures)

yielded products ranging from 250 bp to 4 kb in all five "libraries" (Fig . 3 ). Primary PCR
products were diluted and used as template for a secondary PCR with nested primers
PAS3 and AP2 (see experimental procedures). Libraries 3 and 4 gave approximately 1 . 3
kb and 400 bp products respectively (Fig.4 ), in addition to other smaller size products.
The 1 . 3 kb and 400 bp pieces were then T A-cloned into pGEMT-Easy vector and
sequenced w ith the universal T7 and SP6 primers.

The 1 . 3 kb product from library 3

overlapped w ith the 400 bp product from library 4 and was identical to it in sequence.
Analysis of this sequence revealed the presence of several putative cis-acting elements in
the 5' - flanking region upstream from the first ATG codon. These included hormone
response elements (TRE, GRE, IRS), liver-specific elements (TGT3, HNF) , ubiquitous
transcription factor binding sites (NF-Y, AP I , SP l ) and sterol responsive elements
(SRE).
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Figure 3 . Agarose gel analysis of PCR products amplified from rat PromoterFinder
l ibraries using anchor primer AP I and eDNA specific primer SEQP8. Primary PCR was
performed using the protocol for the PromoterFinder kit as explained in E xperimental
Procedures. Lanes 1 -3 , 5 and 6 correspond to PCR products amplified from libraries I , 2 ,
3 , 4 and 5 respectively. Lane 4 i s a I k b DNA ladder (GIBCO B RL).
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Figure 4. Agarose g e l analysis o f PCR products amplified from rat PromoterFinder
libraries using anchor primer AP2 and nested eDNA specific primer PAS 3 . Secondary
PCR was performed using the protocol for the PromoterFinder kit as explained in
Experimental Procedures. Lanes 1 , 2 and 4 correspond to secondary PCR products
amplified from l ibraries 3, 4 and 5 respectively. Lane 3 is a 1 kb DNA ladder (GIBCO
BRL).
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Figure 5. Nucleotide sequence of the rat CEH promoter. The DNA sequence shown
contains 1 3 1 7 nucleotides of 5 ' - flanking DNA upstream of the ATG initiation codon.
B ases in lower case are identical to the reported CEH eDNA sequence. The transcription
start site identified by primer extension analysis of total liver RNA (shown in Fig. 6) is
indicated by an asterisk ( * ) . Putative transcription factor binding sites are either
underlined or boxed. Sequence identity of the SRE- 1 elements to the consensus SRE- 1
sequence are indicated. AP I : activator protein I ; SRE- 1 : sterol response element- ! ;
HRE: hormone response element ; NF-Y: nuclear factor-Y ; CIEBP: CCAAT/ enhancer
binding protein ; PRS : phorbol ester response sequence ; IRS : insu lin response sequence ;
GRE: glucocorticoid response element ; HNF3 : hepatocyte nuclear factor 3 .

41

- 1317

HNF3
APl
AAACAATAAAGGAAGT C T TAGCAAACATAAAGGAT TGAT TAACTAAATAT

AAAACG TACAATAAT T T C T T T CAT T G T G C TAGT T C T TAAGGGAATAAAAC
GRE / IRS / HNF3
- 1 2 1 7 CAGAAAAACAAGAAAAATCTGTAGAAATGGAGACT GAACAATATAAT T CA
- 12 67

- 1 1 67

CAAT GAACAGC GAT T CAC T GAAGAAATAGG GGAAAGG GAG G G T T G TAAAA

- 1 1 17

T T C C T TAAG TGAAATAAGAACAGAAATACCGCATATAGGACT GAGATAAA

ACAAAAG T T G T T C T GGGGGAAAT T C T C TATCATGACCATC TACAG T C T TA
APl
- 1 0 1 7 T G T C T T GAAGAAGACATAAT TATGCAT CAAAGG GAC T TAAATT CACAGAA
- 10 67

- 9 67

TAG TAC C T C C C TGGGCTGTAGAATAC T TAT TAG T T TATCAG C T CAT GGAA

-917

-8 17

AT T T T T CCAAAATAGATAAG T T GAAGAGAT T T GAT C T TAAAGGAAC TAAA
C/EBP
GAT T C C TAAAAA T GAAGCAAATGATGTAGTAAT GCATCCAGAGAAC T TAA
GRE / IRS / PRS
AAATAAG T G G T TGGG TAAAACAACCAAATACACAACAGGGGAAT GAAAAG

-7 67

AGGTAGCCATACACAAAAGCAT GAAGAGGC TACAC T G T T G GAACAGGCTA

-7 1 7

GC CAGCAAT T C CAGAGACACACCAC T T T G C T G TACAT T G TGCAT T CCCAC

-667

GAAGAGAGAGGCCAT GTAC T T CAGTAAAT G T T T GAAGAAT CAG T GCACAA

-617

G TACAT T CATGGAT TATGAGG T G C CAGTAGAG T T T G T T TAC CATATAAAC

-567

G T TATGT C CAAAG G T T C T T T C T C T GAGAGGTAAAC T T C C T TGAGCCTGAG

-517

TAT GCAC C T T G C C TAGCCAAGTCAC T T GACAGGAATAC T G T GAAGATAAT

- 4 67

T TAAGAATC G T C T GAAG G T C TG TAGGTGGTGAG G T T T C T T C C TAAC T TGA

-417

GAATAT GGAT T C TAGGAAAT GCCAG T C CCAGAGAG G C T G T GAGAAATG T G

- 3 67

- 1 17

T T C T CAC T T C CCAT C T GAGCAGAGTGGGAATGAGAGGTAT T C TAATAT GT
SRE l 7 / 8
IRS / PRS
T CATCT T T GTAAAAGGACC CCAGACCAACCCT TGCCACTAAC TGCAGGCA
PRS
G C T G C C T G C T G C T G T C T G C T C T T GAGAGT TCAAGAGCAT T GAAT T GAGGT
C / EBP
GAGAG T G C T G GAGGGAAAAC TGCT TATGTAAGAAG C T G T T G GATGAG T T T
SRE l 6/8 HRE
AP l
APl
HRE
TAC TGAC G T T C
ATAAAAG TG
C TAGC C C T T G
T T A AT TG
SPl SRE
GG TAAAC T C T T GGTG
T
C T T GAGATC C CAAC T G G CAC CCAGAGA

-67

G C T C T T T GGAAGGGAGAGC T T T TCT GT CAT C T TAAATTAC a t c t g t g g g c

- 17

t a t t t g t t cc t tccacaatgcgc

- 8 67

-317
-2 67
-217
- 1 67

f

�

�

*

M e t Arg

Ap

42
Fig.5 shows the nucleotide sequence of the cloned 1 . 3 kb of the promoter for the rat CEH
gene as well as some of the putative cis-acting elements.
Primer Extension Analysis
Primer extension analysis was performed to identify the transcription start site.
32
The CEH eDNA specific primer PAS3 was radiolabelled with [y- P] ATP and annealed
to rat l iver total RNA ( 1 5 llg). The primer was extended with AMY reverse transcriptase
°
( 1 . 3 U) for 30 min. at 42 C. The primer extension products were analyzed on an 8 %
denaturing polyacrylamide g e l fo llowed by autoradiography for 1 6 hrs. (Fig.6, lane 2 ) .
Radiolabelled standards were used t o determine the size o f the primer extension product
( lane I ). The primer by itself ( lane 3) did not give any product. However the primer in
the presence of RNA gave a single 66 bp product.

Comparison of the length of this

product to the DNA sequence of the 5 ' -flanking region allowed the approximate
posit ionin g of the 5' end of the CEH mRNA at nucleotide -60 upstream from the
in itiation ATG codon (Fig . 5 ) . Although no canonical TATA-box sequences were found
around the transcription start site, a consensus GC-box which binds the positi ve
transcription factor SP I , was found 35 bases upstream from the start site (Fig.5)
Generation of rat CEH promoterlluciferase chimeric genes
About 1 . 3 kb of the promoter was cloned into the luciferase reporter vector pGL3B asic as detailed in Experimental Procedures, to generate p- 1 3 1 7Luc.

The remaining

constructs were obtained by generation of unidirectional nested deletion breakpo ints in p1 3 1 7Luc w ith Exonuclease III.

Fig.7 shows the products generated by this procedure.

43

Figure 6. Determination of transcription start site of rat CEH gene by primer extension
analysis. Radio labelled primer PAS3 corresponding to regions 6 to -2 1 of the published
eDNA sequence was annealed to total l iver RNA ( 1 5 IJ.g) and extended w it h AMY
reverse transcriptase ( 1 . 3 U) as explained in Experimental Procedures. DNA size
markers are shown in lane l . The primer extension product corresponding to 60
nucleotides upstream of the ATG initiation codon is shown in lane 2. Radiolabelled
primer by itself is shown in lane 3 .
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Figure 7. Agarose gel analysis of deletion products obtained by digestion of p- 1 3 1 7Luc
by Exonuclease III for generation of rat CEH promoterlluciferase chimeric genes. The
ful l length construct p- 1 3 1 7Luc (lane 1 ) was digested w ith Exonuclease III as explained
in Experimental Procedures. Aliquots removed at 1 min intervals were run on a 0 . 8 %
agarose g e l ( lanes 2- 1 1 ) . S ize of the deleted products were estimated by comparison t o a
1 kb DNA ladder (GIBCO BRL).
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Aliquots removed at I min. intervals were run on a 0.8% agarose gel along with
l inearized p- 1 3 1 7Luc (Fig.7, lane 1 ) . A I kb DNA ladder was run on the gel in order to
estimate the size of the products obtained.

These products were re-ligated and

transformed into TOP I OF' cells. The plasmjds obtained were digested with restriction
enzymes and sequenced with universal T7 and SP6 sequencing primers to deterrrune the
exact position of the breakpo int. They were then purified by double banding in cesium
chloride or with Qiagen columns.
Promoter activity in HepG2 ceUs
Determination of basal CEH promoter activity
To deterrrune the basal promoter activity of the rat CEH gene, confluent HepG2
cells were transfected with CEH promoter/luciferase chimeric genes shown in Fig . 8 . As
shown in Fig.9 full-length and deletion clones were more active than the promoter-less
pGL3-Basic by itself. CEH/luciferase chimeric genes downstream of, and including p599Luc increased luciferase reporter activity 1 .6 to 2 fold as compared to the longest
construct p- 1 3 1 7Luc.

This suggests that positive cis-acting elements are located

downstream of nt-599 and repressor sequences upstream of nt-599.
Effect of dexamethasone on CEH promoter activity
Previous studies have shown that glucocorticoids can either stimulate or inhibit
CEH activity when administered in vivo (Gandarias et al, 1 984; Grogan et al, 1 99 1 ). In
cu ltured primary rat hepatocytes, dexamethasone was required to maintain steady-state
CEH mRNA levels (Ghosh et al, 1 997 ; manuscript submitted). When HepG2 cells were
transfected w ith p- 1 3 1 7Luc and treated with increasing concentrations of dexamethasone,

48

Figure 8 . Illustration of rat CEH/luc iferase chimeric genes used in this study. Deletion
c lones were generated by PCR or by Exonuclease III digestion as described in
Experimental Procedures. Numbers are relative to the ATG initiation codon of the CEH
eDNA.
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Figure 9. Basal promoter activity of the rat CEH/luc iferase chimeric genes transfected
into HepG2 cells. Confluent HepG2 cultures were transfected as described under
Experimental Procedures and incubated for 40 hrs. in serum free medium. At the end of
the incubation, cells were harvested and reporter enzyme activities were determined as
described. Normalized promoter activities are expressed as percentage of control (pGL3B asic) and represent the mean ± S. E. M. of 3 independent determinations; (*) indicates
difference at p<O.OO I .
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Figure 1 0. Effect of dexamethasone on the promoter activity of the CEH gene in HepG2
cells. (A) Confluent HepG2 cultures were transfected with p- 1 3 1 7Luc and incubated for
40 hrs. in serum free medium containing increasing concentrations of dexamethasone.
Results are expressed as the ratio of luciferase and �-galactosidase activities and
represent the mean ± S. E. M. of 3 independent determinations. Basal activity of p1 3 1 7Luc in the absence of dexamethasone was 1 453 RLU/mU �-galactosidase. (B)
Confluent HepG2 cultures were transfected with the indicated rat CEH/luciferase
chimeric genes and incubated for 40 hrs. in serum free medium containing either 0. 1 11M
dexamethasone in ethanol or ethanol alone. Normalized promoter activities are expressed
as percentage of control and represent the mean ± S. E. M. of 3 independent
determinat ions; ( * ) indicates difference at p<O.OO I .
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promoter activity increased approximately 4.5 fo ld at 0. 1 f.!M dexamethasone (Fig . ! OA).
In order to map the regions that respond to dexamethasone, reporter activity of each
construct was measured in the presence of 0. 1 f.!M dexamethasone (Fig. I OB) . Deletion of
the promoter to nt- 1 1 90 eliminated the induction observed with the full-length construct.
Further deletion down to nt-859 restored the activation to 2.4 fo ld.

However the

remaining constructs did not show any induction by dexamethasone suggest ing that two
regions mediate the g lucocorticoid effect, one located between nt- 1 3 1 7 and nt- 1 1 90 and
the other between nt-859 and nt-540.
Regulation of CEH promoter activity by thyroid hormones
Earlier work from this laboratory showed that L-thyroxine (T4) was required in
conjunction w ith dexamethasone to maintain steady-state CEH mRNA levels in cu ltured
rat primary hepatocytes (Ghosh et al, 1 997; manuscript submitted).

Hoekman et al

( 1 993) reported that the C7aH gene is activated by T4. Karam and Chiang also observed
that T4 increases C7aH mRNA levels in HepG2 cells.

HMGCoAR mRNA also

increased in the presence of T4 although this increase resulted from stabilization of the
mRNA rather than increased transcription (S imonet and Ness, 1 989).

Therefore, we

tested the effect of L-thyroxine on the transcriptional act ivity of the CEH promoter. As
shown in Fig. I I A, T4 stimu lated the promoter activity of p- 1 3 1 7Luc at a concentration
as low as 0.0 I f.!M with maximal effect ( 4 fold) at 0.0 I - 1 .0 f.! M . T4 stimulated the
activity of all the deletion clones tested except for p- 1 1 90Luc, for which the activity
stayed at basal levels ( Fig. ! ! B ) . Therefore, two regions respond to T4, one between nt1 3 1 7 and nt- 1 1 90 and the other between nt-226 and nt-37.

55

Figure I I . Effect of L-thyroxine on the promoter activity of the rat CEH gene in HepG2
cells. (A) Confluent cultures of HepG2 cells were transfected w ith p- 1 3 1 7Luc and
incubated for 40 hrs. in serum free media containing increasing concentrations of L
Thyroxine. The results are expressed as the ratio of luciferase and �-galactosidase
activities and represent the mean ± S. E. M. of 3 independent determinations. B asal
activity of p- 1 3 1 7Luc in the absence of L-thyroxine was 1 453 RLU/mU �-galactosidase.
(B) Confluent HepG2 cells were transfected with the indicated rat CEH!Iuciferase
chimeric genes and incubated for 40 hrs. in serum free medium in the presence of 1 .0 11M
L-Thyroxine or vehicle alone. Results are expressed as the ratio of luciferase and �
galactosidase activities and represent the mean ± S. E. M. of 3 independent
deterrrtinat ions; ( * ) indicates difference at p<O.OO I .
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Effect of phorbol esters on the CEH promoter activity
Previous studies from this laboratory have shown that CEH is activated in vitro by
reversible phosphorylation (Ghosh and Grogan, 1 989). On the other hand, the protein
kinase C (PKC) activator, 4�-phorbol- 1 2-myristate- 1 3-acetate (PMA), decreased CEH
mRNA by 49% in cu ltured rat primary hepatocytes (Ghosh et al, 1 997 ; manuscript
submitted). This maximal decrease was observed after a 6 hr. incubation in PMA.

In

order to determine the invo l vement of a PKC-mediated signal transduction pathway in
the regulation of CEH gene transcription, transfection experiments were performed in the
presence of I !J M PMA.

Since long exposures to PMA depletes PKC activity in cells

(Young et al, 1 987), a time course experiment was performed to determine the optimal
incubation time in PMA.

When HepG2 cells were transfected with p- 1 3 1 7Luc and

exposed to I !JM PMA for different periods of time, the promoter activity was decreased
by 34% after a 6 hr. incubation in PMA (Fig. l 2A) . Further exposure to PMA for 24 hrs.
caused the promoter activity to increase to 1 60% suggesting that the optimal incubation
time in PMA was 6 hrs. In order to map the regions that respond to PMA, HepG2 cells
were transfected with various CEH promoter/luciferase chimeric genes and exposed to
I !J M PMA for 6 hrs. As seen in Fig. I 2B, the promoter activity of all the deletion clones
except for p-540Luc were repressed.

The maximal decrease was observed with p-

4 1 8Luc, the activity of which was only about 36% of control, suggesting the presence of
negative phorbol ester responsive sequences (PRS) in the region from nt-859 to nt-54 1 ,
nt-4 1 8 to nt-227 and nt-226 to nt-37 and a positive PRS between nt-540 to nt-4 1 9 .
Effect of agents that perturb cholesterol metabolism on CEH promoter activity
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Figure 1 2. Effect of phorbol esters on the promoter activity of the rat CEH/luc iferase
chimeric genes in HepG2 cells. (A) Confluent HepG2 cells were transfected with p1 3 1 7Luc and fed w ith serum free medium containing I IJ.M PMA in DMSO or DMSO
alone. Cells were harvested at the indicated times and reporter enzyme activities were
determined. Results are expressed as percentage of control of normalized luciferase
activity and represent the mean ± S. E. M. of 3 independent observations. (B) Confluent
HepG2 cells were transfected with the indicated rat CEH/luciferase gene constructs.
They were incubated in serum free medium with I IJ.M PMA in DMSO or DMSO alone
for 6 hrs. and then harvested. Normalized promoter activities are expressed as percentage
of control and represent the mean ± S. E. M. of 3 independent obsevations. (*) indicates
difference at p<O.OO I ; ( * * ) indicates difference at p<0.005 ; ( * * * ) indicates difference at
p<O.O l .
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Perturbations of cellular cho lesterol metabolism by agents that increase or decrease levels
of intracellular cholesterol have a marked effect on CEH mRNA, protein and act ivity.
Intravenous infusion of mevalonate, an agent known to increase levels of intracellular
cholesterol, caused a compensatory decrease in CEH activity and protein mass (Ghosh et
al, 1 997; manuscript submitted) . Moreover, lovastatin, a potent competitive inhib itor of
HMGCoAR, increased CEH mRNA 2 fo ld in cu ltured primary rat hepatocytes (Ghosh et
al,

1 997 ;

manuscript

submitted).

Therefore,

in order to determine the sterol

responsiveness of the CEH gene, we tested the effect of mevalonate and squalestatin, an
inhibitor of squalene synthase and cho lesterol biosynthesis, on the transcriptional activity
of the CEH promoter. Mevalonate (2 mM) treatment for 24 hrs. repressed reporter gene
activity of p- 1 3 1 7Luc and p- 1 1 90Luc to 26% and 1 6% of control respectively (Fig. l 3A) .
Luciferase reporter activity was restored to basal levels in p-859Luc. However activity of
p-226Luc was only 43% of control, suggesting that sterol response elements (SRE) are
present between nt- 1 1 90 and nt-859, nt-4 1 8 and nt-227, and betwen nt-226 and nt-3 7 .
S imultaneous treatment for 2 4 hrs. with 2 m M mevalonate and I 11 M squalestatin
restored the activity of p-226Luc (Fig. I 3B ) , but failed to bring the activity of p- 1 1 90Luc
back to basal levels.

It therefore appears that strong negative SRE ' s may be located

between nt-226 and nt-37 and a positive S RE may be present between nt-4 1 8 and nt-227 .
Inasmuch as squalestatin did not reverse the inhibition associated with p- 1 1 90Luc, it is
possible that the region between nt- 1 1 90 and nt-859 is uniquely responsive to non-sterols.
The positions of the variuos GRE's, TRE's, PRS and SRE ' s in the rat CEH
promoter, that were ident ified by transient transfections in human hepatoblastoma HepG2
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Figure 1 3 . Effect of cholesterol perturbing agents on the promoter activity of rat
CEH/Iuciferase chimeric genes in HepG2 cells.
Confluent HepG2 cultures were
transfected w ith the indicated rat CEH/Iuc iferase promoter constructs and incubated for
24 hrs. in serum free medium in the presence or absence of 2 mM mevalonolactone
alone, (A) or 2 mM mevalono lactone and I J..lM squalestatin, (B). Normalized promoter
activities are expressed as percentage of control and represent the mean ± S. E. M. of 3
separate observation s ; ( * ) indicates difference at p<O.OO I ; ( * *) indicates difference at
p<0.00 5 ; ( * * * ) indicates difference at p<O.O J .
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Figure 1 4. Position of cis-acting elements in the rat CEH promoter identified by transient
transfect ions in HepG2 cells. This figure shows the approximate positions of the various
response elements identified in the rat CEH promoter by transient transfections in HepG2
cells. The mapping of each individual response element is explained in the Results
section. GRE: glucocorticoid response element ; HRE: hormone response element ; PRS:
phorbol ester response element ; SRE: sterol response element ; TRE: thyroid hormone
response e lement.
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cells, is shown in Fig. 1 4.
P romoter activity in primary rat hepatocytes
Determination of basal CEH promoter activity
The basal CEH promoter activity in primary rat hepatocytes was determined by
transfection of cultured hepatocytes with the different CEH promoter/luciferase chimeric
genes shown in Fig . 8 . A s shown i n Fig. l 5 , fu ll- length and deletion clones were more
active than the promoter-less pGL3-Basic by itself. The CEH/luc iferase chimeric genes
downstream of, and including p-599Luc increased luciferase reporter activity 1 .6 to 4
fold as compared to the longest construct p- 1 3 1 7Luc.

This suggests that positive cis

acting elements may be located downstream of nt-599 and repressor sequences upstream
of nt-599.
Effect of dexamethasone on CEH promoter activity
As shown earlier, dexamethasone at 0. 1 f.! M increased CEH promoter activity in
HepG2 cells.

The same concentration of dexamethasone was also required,

in

conjunction w ith T4 to maintain the CEH steady state mRNA levels in cultured rat
primary hepatocytes (Ghosh et al, 1 997 ; manuscript submitted) .

Moreover, the C7aH

promoter was maximally responsive to dexamethasone at 0. 1 to 1 .0 f.!M (Crestani et al,
1 995). Therefore, in order to map the regions that respond to dexamethasone in primary
rat hepatocytes, they were transfected with different CEH promoter/luciferase chimeric
genes and incubated for 40 hrs in the presence or absence of 0. 1 f.! M dexamethasone
(Fig. l 6) . The smallest construct p-226Luc increased luciferase reporter activity 4.5 fo ld.
The activity of p-4 1 8Luc was only 1 . 8 fo ld. However p-540Luc also induced promoter
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Figure 1 5 . B asal promoter activity of the rat CEWluciferase chimeric genes transfected
into primary rat hepatocytes. Cultured primary rat hepatocytes were transfected as
described under Experimental Procedures and incubated for 40 hrs. in serum free
medium. At the end of the incubat ion, cells were harvested and reporter enzyme
activities were determined as described. Normalized promoter activities are expressed as
percentage of control (pGL3-Basic) and represent the mean ± S. E. M. of 3 independent
determinat ions ; ( *) indicates difference at p<O.OO I .

67

p- 1 3 1 7 Lu c
p- l l 90 L u c
p-85 9 L u c
*

p-5 9 9 L u c
p-54 0 L u c
p-4 1 8 L u c
p-22 6 L u c

*

0

1 00

200

300

400

500

R L U /m U 8 - g a l a ctos i d ase

600

68

Figure 1 6. Effect of dexamethasone on the promoter activity of the CEH gene in primary
rat hepatocytes. Cultured primary rat hepatocytes were transfected with the indicated rat
CEH/Iuciferase chimeric genes and incubated for 40 hrs. in serum free medium
containing either 0. 1 j..L M dexamethasone in ethanol or ethanol alone. Normalized
promoter activities are expressed as percentage of control and represent the mean ± S. E.
M. of 3 independent determinations; (*) indicates difference at p<O.OO I ; (**) indicates
difference at p<0.005.
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activity to 3 . 5 fold of control. S imilarly p- 1 1 90Luc stimulated the promoter activity 4.7
fo ld.

These results suggest that dexamethasone induces CEH promoter activity in

primary rat hepatocytes through three regions, one located between nt- 1 1 90 and nt-859,
one between nt-540 and nt-4 1 8 and the third between nt-226 and nt-37.
Regulation of CEH promoter activity by L-thyroxine
Previous work from this laboratory showed that T4 ( 1 .0 !J M) was required w ith
dexamethasone to maintain CEH steady state mRNA levels (Ghosh et al,

1 997;

manuscript submitted) . As shown earlier T4 stimulated CEH promoter activity in HepG2
cells at 0.0 1 - 1 .0 !J M .

Therefore we tested the effect of T4 ( 1 .0 !J M) on the

transcript ional activity of the CEH promoter in primary rat hepatocytes (Fig. 1 7) .
induced the promoter activity of p- 1 1 90 by 2.7 fold.
decreased the induction to 1 .5 fold.

T4

Deleting down to p-859Luc

The remaining constructs demonstrated the same

level of induction as p-859Luc suggesting that two regions mediate the T4 effect in
hepatocytes, one located between nt- 1 1 90 and nt-859 and the other between nt-226 and
nt-37.
Effect of phorbol esters on the CEH promoter activity
As mentioned before, the PKC activator, PMA, decreased CEH mRNA by 49% in
rat primary hepatocytes (Ghosh et al, 1 997; manuscript submitted).

CEH promoter

activity was also decreased by 64% in HepG2 cells after a 6 hr incubation in PMA.

In

order to determine the invo lvement of a PKC-mediated signal transduction pathway in
the regulation of CEH gene transcript ion in primary rat hepatocytes, transfection
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Figure 1 7 . Effect of L-thyroxine on the promoter activity of the rat CEH gene in primary
rat hepatocytes. Cultured primary rat hepatocytes were transfected with the indicated rat
CEH/Iuciferase chimeric genes and incubated for 40 hrs. in serum free medium in the
presence of 1 .0 f.LM L-thyroxine or vehicle alone. Results are expressed as the ratio of
luci ferase and �-galactosidase activities and represent the mean ± S. E. M . of 3
independent determinations; (*) indicates difference at p<O.OO I .
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experiments were performed in the presence o f PMA ( I f1 M ) . A time course experiment
was first performed to determine the optimal incubation time in PMA. When primary rat
hepatocytes were transfected with p- 1 3 1 7Luc and exposed to PMA for different periods
of time, the promoter activity was decreased by 35% after an 8 hr. incubation in PMA
(Fig. 1 8A). To determine the PMA responsive regions, hepatocytes were transfected with
various CEH promoterlluc iferase chimeric genes and exposed to I f1M PMA for 8 hrs.
As seen in Fig . I 8B only the promoter activity of p- 1 3 1 7Luc was repressed. Therefore a
negative PRS may be located in the region between nt- 1 3 1 7 and nt- 1 1 90.
Effect of agents that perturb cholesterol metabolism on CEH promoter activity
As mentioned before perturbations of cellular cholesterol metabolism have a
marked affect on CEH mRNA, protein and activity. Therefore, in primary hepatocytes,
as w ith HepG2 cells, we tested the effect of mevalonate and squalestatin on the
transcriptional activity of the CEH promoter. Mevalonate (2 mM) treatment for 24 hrs.
repressed the reporter activity of p- 1 3 1 7Luc to 49% of control (Fig. l 9A).
reporter activity was restored to basal levels in p- 1 1 90Luc.

Luciferase

However activity of p-

226Luc was only 74% of control, suggesting that sterol response elements (SRE) are
present between nt- 1 3 1 7 and nt- 1 1 90 and between nt-226 and nt-37.

Simu ltaneous

treatment for 24 hrs. with 2 mM mevalonate and I 11M squalestatin restored the activity
of p-226Luc (Fig. 1 9B ) , but failed to bring the activity of p- 1 3 1 7Luc back to basal levels.
It therefore appears that a negative S RE may be located between nt-226 and nt-3 7 .
Inasmuch a s squalestatin d i d not reverse the inhibition associated with p- 1 3 1 7Luc, i t i s
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Figure 1 8 . Effect of phorbol esters on the promoter activity of the rat CEH/Iuciferase
chimeric genes in primary rat hepatocytes. (A) Cultured primary rat hepatocytes were
transfected with p- 1 3 1 7Luc and fed with serum free medium containing I jlM PMA in
DMSO or DMSO alone. Cells were harvested at the indicated times and reporter enzyme
activit ies were determined. Results are expressed as percentage of control of normalized
luciferase act ivity and represent the mean ± S. E. M. of 3 independent observations. (B)
Cultured primary rat hepatocytes were transfected with the indicated rat CEH/luciferase
gene constructs. They were incubated in serum free medium with I jlM PMA in DMSO
or DMSO alone for 6 hrs. and then harvested. Normalized promoter activities are
expressed as percentage of control and represent the mean ± S . E. M. of 3 independent
obsevations. ( * * ) indicates difference at p<0.005.
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Figure 1 9. Effect of cho lesterol perturbing agents on the promoter activity of rat
CEH/Iuciferase chimeric genes in primary rat hepatocytes. Cu ltured primary rat
hepatocytes were transfected with the indicated rat CEH/luciferase promoter constructs
and incubated for 24 hrs. in serum free medium in the presence or absence of 2 mM
mevalono lactone alone, (A) or 2 mM mevalono lactone and I 11M squalestatin, (B).
Normalized promoter activities are expressed as percentage of control and represent the
mean ± S. E. M. of 3 separate observat ions ; (**) indicates difference at p<0.005.
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Figure 20. Positions of cis-acting elements in the rat CEH promoter identified by
transient transfect ions in primary rat hepatocytes. This figure shows the approximate
positions of the various response elements identified in the rat CEH promoter by transient
transfections in primary rat hepatocytes. The mapping of each response element is
explained in the Results sect ion. GRE: glucocorticoid response element ; PRS : phorbol
ester response element ; SRE: sterol response element ; TRE: thyroid hormone response
element.
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possible that the region between nt- 1 3 1 7 and nt- 1 1 90 is uniquely responsive to nonsterols. Figure 20 shows the positions of these cis-acting elements in the CEH promoter.

DISCUSSION

This dissertation describes the isolation and characterization of the rat neutral
hepatic CEH promoter.

The rat CEH promoter is unusual in that it has no consensus

TATA-box seque nces immediately upstream of the transcription init iation site. However
the promoter does have a GC-box sequence, which can bind the positive transcription
factor S P l to drive transcription, and an inverted CCAAT box, which can bind another
positi ve transcription factor NF-Y.

In this respect the CEH promoter resembles the

promoter for the HMGCoAR gene and the human squalene synthase gene, which also
lack TAT A-box
transcription.

like sequences but utilize

several GC-box sequences to drive

The upstream regions of the promoter invo lved in transcriptional

regulation were also characterized. Two different cel l l ines were used for this purpose: a
homologous system of rat primary hepatocytes and a heterologous system consisting of
human hepatoblastoma HepG2 cells.
To gain insight into the molecular mechanisms invo lved in the regulation of CEH,
an in vitro primary rat hepatocyte cell culture system was optimized in this laboratory by
Ghosh et al. I n this optimized system, insulin, dexamethasone (0. 1 !lM) and L-thyroxine
( 1 .0 11M) were required to maintain CEH mRNA at steady-state levels. The HepG2 cell
line is commonly used to study the regulation of cholesterol homeostasis.

Most

intermediates in the bile acid pathway have been detected in HepG2 cells, and the defects
81
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previously reported were due to culture conditions.
resolved.

These defects have now been

HepG2 cells exhibit an adult/terminal phenotype when grown to confluence

and retain many cholesterol homeostatic functions (Kelly et al, 1 989; Kosaki et al, 1 993).
They synthesize apolipoproteins B- 1 00, C-11, C-III, E, A-I, A-I I and A-IV (Gordon et al,
1 98 3 ; Gordon et al, 1 984; Rash et al, 1 98 1 ; Tam et al, 1 985; Zannis et al, 1 98 1 ), express
functional receptors for low density lipoproteins, high density l ipoproteins, insulin,
transferrin, estrogen and asialoglycoprotein (Wu et al,

1 984; Hoeg et al, 1 985),

synthesize and secrete lipoproteins (Rash et al, 1 98 1 ; Tam et al, 1 98 5 ; Zannis et al,
1 98 1 ),

and

express

sterol-27-hydroxylase,

HMGCoAR,

lecithin:cholesterol

acyltransferase and ACAT (Erickson and Fielding, 1 986; Martin et al, 1 993). Hence, this
cell line is also a suitable model in which to study the regulation of CEH.
The hepatic CEH promoter was characterized both under basal conditions and in
the presence of various physiological stimuli. Studies in both cell l ines showed that the
proximal 599 base sequences of the promoter contains activator elements that are l inked
to distal repressor regions by a TC-rich hinge located between nt-780 and nt-765 , similar
to the TC-rich hinge found in the C7H promoter. The promoter also contains putative
cis-acting elements, including several hormone response half-elements, sterol response
elements, ubiquitous transcription factor binding sites and l iver specific elements, some
of which are shown in Fig. 5. These putative elements were identified using the GCG
program

(SITED ATA).

One

liver-enriched

transcription

factor,

CIEBP

(CCAAT/enhancer binding protein) putatively binds to the promoter between nt- 1 94 and
nt- 1 86, and between nt-843 and nt-835, and may be required for the developmental
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regulation and maintenance of the expression of genes.

CEH mRNA, protein and

enzyme activity have been shown to be developmentally regulated both in male and
female rats (Natarajan et al, 1 996; Natarajan et al, 1 997). Thus, the presence of putative
binding sites for C/EBP and possibly DBP (albumin D-site binding protein) supports the
"establishment v/s maintenance" model proposed in the developmental regulation of
other liver-specific genes such as PEPCK (phosphoeneol pyruvate carboxykinase) and
albumin (Crestani et al, 1 995).
I n HepG2 cells the response to glucocorticoids was seen primarily in the distal 5'
flanking sequences. The activation, by dexamethasone, in the region between nt- 1 3 1 7
and nt- 1 1 90 was nearly twice that seen in the region between nt-859 and nt-540. This
region between nt- 1 3 1 7 and nt- 1 1 90 has a sequence similar to the sequence w ithin the
glucocorticoid response unit (GRU) of the PEPCK gene.

The complex GRU of the

PEPCK gene has 2 glucocorticoid receptor (GR) binding sites and 2 sites recognized by
accessory

factors

AF I

and

AF2.

The

sequence

in

the

CEH

promoter,

TTTTGGTCTTTTTGTTCTTTTTAGACATCT, is located between positions - 1 1 85 to 1 1 56.

It contains an imperfect palindrome TCTAGAgatTTTTCT which closely

resembles

the

consensus

glucocorticoid

response

(T/G)GTACAnn nTGTTCT, where n stands for any nucleotide.

element

(GRE)

The consensus GRE

directs the specific binding of the GR to DNA in the promoter region of target genes with
one molecule of the GR binding to each of the two half-s ites in a cooperative manner.
The 5 ' portion of this sequence, TCTGGTTTT, located between nt- 1 1 77 and nt - 1 1 85 is
virtually identical to the recognition sequence TGTGGmT, for accessory factor AF2 in
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the PEPCK promoter. Imai et al showed that proteins other than the GR are required for
activation of glucocorticoid-inducible genes, and that accessory factors AF I and AF2 do
not act in the absence of the two GR binding regions. The AF2 element has also been
shown to be an insulin response sequence ( IRS) which opposes the dexamethasone
mediated stimulat ion, both in PEPCK and C7H genes.

Although we did not test the

effect of insulin on the CEH promoter in this study, it has been shown that a min imum of
24 hrs. incubation of rat primary hepatocytes in insul in containing medium is essential to
observe the synergistic increase in CEH mRNA by T4 and dexamethasone (Ghosh et al,
manuscript submitted).

Therefore it appears that the CEH gene may also contain a

complex g lucocorticoid response unit with a glucocorticoid response element, an insulin
responsive sequence and other sequences that mediate the insulin effect in the distal
regions of the promoter.
S imilarly,

the

region

between

nt-859

and

nt-540

has

the

sequence

TGTTGTGTATTTGGTTGTITI at positions -78 1 to -80 1 , which could also behave as
a glucocorticoid response unit and account for the dexamethasone mediated stimulation
in this region.
On the other hand, three entirely different glucocorticoid response regions were
mapped by transient transfections in primary rat hepatocytes.

These glucocorticoid

response regions were located between nt- 1 1 90 and nt-859, between nt-540 and nt-4 1 8
and between nt-226 and nt-37. The region in the CEH promoter between nt- 1 1 90 and nt859 has the sequence TCTTGT between nt - 1 1 0 I and nt- 1 096. This sequence is identical
to the human glucocorticoid response element 5 (HGRE5; von der Ahe et al, 1 985). This
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region also contains another sequence TCCTGA between nt- 1 08 1 and nt- 1 076 which is
identical to the human glucocorticoid response element 7 (HGRE7 ; Cato et al, 1 985). In
addition the region between nt-540 and nt-4 1 8 has the sequence TGAAGA between nt534 and nt-528 which closely resembles the core sequence of the GRE (TGTAGGA - 5 ' )
reported by Langer and Ostrowski. Finally the region between nt-226 and nt-37 contains
the sequence GGTACTGACTGTTCA between nt- 1 42 and nt- 1 28 which resembles the
consensus sequence for the GRE (GGTACAnnnTGTTCT; Beato, 1 989)
Thus, it is evident that while dexamethasone stimulated reporter gene activity in
both HepG2 cells and primary rat hepatocytes, the glucocorticoid response regions
mapped were different in each cell l ine.

This variation could have arisen due to the

different cellular context and underscores the importance of a careful evaluation of the
cellular environment (HepG2 cells v/s cultured primary hepatocytes) and the effect of the
species ( man v/s rat) prior to extrapolating the data to an in vivo condition.
Thyroid hormones stimulated reporter gene activity in both HepG2 cells and
primary rat hepatocytes. With HepG2 cel ls, activation regions were mapped between nt1 3 1 7 and nt- 1 1 90 and between nt-226 and nt-37. Both these regions have sequences that
partiall y match the consensus type II steroid/thyroid hormone response element
AG(G/T)TCA, although there were no sequences that exactly matched the consensus
thyroid hormone response element (TRE) TCAGGTCA---TGACCTGA. Similarly in the
case of primary rat hepatocytes, activation regions were mapped between nt- 1 1 90 and nt859 and between nt-226 and nt-37. The region between nt- 1 1 90 and nt-859 contains a
sequence that partially matched the consensus type II steroid/thyroid hormone response
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e lement, but none that exactly matched the consensus TRE. As mentioned before, it has
been shown that T4, along with insulin and dexamethasone, was essential to maintain
CEH mRNA in cu ltured primary rat hepatocytes.

It has also been shown that the

expression of several liver specific genes in cultures of primary rat hepatocytes is
abolished unless hormones are added to serum-free medium. Therefore it appears that
further studies such as mutational analysis would be essential to identify and map the
thyroid hormone response element in the CEH promoter.
The tumor promoter PMA repressed the transcriptional activity of the CEH gene,
both in HepG2 cells and in primary rat hepatocytes. Whereas PMA is a known activator
of PKC, long term exposures to PMA cause PKC to be proteolyt ically inactivated (Young
et al, 1 987). A time course experiment was therefore performed to determine the optimal
incubation time of each cell line in PMA. In HepG2 cells maximal inactivation occurred
after 6 hrs. exposure to PMA.

On the other hand, in primary rat hepatocytes a time

course experiment showed maximal inactivation after 8 hrs. exposure to PMA.

With

HepG2 cells, negative PRS were mapped between nt-859 and nt-54 1 , nt-4 1 8 and nt-227,
and nt-226 and nt-37. A positive PRS was also mapped in the region between nt-540 and
nt-4 1 9 . However in primary rat hepatocytes, only a single negative PRS was identified
between nt - 1 3 1 7 and nt - 1 1 90.

PMA affects transcription of several genes through

phosphorylation of transcription factors like c-Jun, c-Fos and NFKB .

Jun/Fos

heterodimers mediate their effects by binding to AP- I like elements. Several AP- I like
sequences with the invariant half-site TCA and the conserved T-nucleotide that are
crucial for the binding of Jun!Fos are present between nt-226 and nt-37.

The region
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between nt-4 1 8 and nt-227 also has the sequence TCfTGT that resembles the IRS/PRS
of both the rat and the hamster C7H gene. As discussed previously, the region between
nt-859 and nt-54 1 includes the sequence TGTTGTGTATTTGGTTGTTTI that resembles
the IRS/PRS of the PEPCK gene (Imai et al, 1 990). These sites could therefore account
for the effects observed with PMA in HepG2 cells.
S imilarly the region between nt- 1 3 1 7 and nt- 1 1 90 has an AP- I like sequence
TGATTAA between nt- 1 282 and nt- 1 276 that could confer PMA responsiveness in
primary

rat

hepatocytes.

This

region

also

includes

the

sequence,

TTTTGGTCTTTTTGTTCTTTTTAGACATCT located between nt- 1 1 85 and nt- 1 1 56,
that resembles the IRS/PRS of the PEPCK gene (O'Brien et al, 1 99 1 ) as well as the
IRStrGT4/HNF3 of the C7H gene (Crestani et al, 1 995).

Thus it appears that signal

transducing agents p lay a significant role in the transcriptional regulation of the CEH
gene.

Moreover, bile acids have been reported to down-regulate the C7H gene

transcription, partly through the PKC signal transduction pathway (Stravitz et al, 1 995).
It would be reasonable to postulate that the CEH gene is regulated in a similar fashion by
bile acids, especially since it has been shown that taurocholate suppresses CEH mRNA
levels in primary rat hepatocytes (Ghosh et al, 1 997 ; manuscript submitted)
In this study known cho lesterol perturbing agents were used to alter intracellular
cholesterol levels in HepG2 cells and in primary rat hepatocytes. The agents used were
mevalanolactone and squalestatin.
pathway.

Cholesterol is the major product of the mevalonate

In addition several biologically important non-sterol products such as

isopentenyl adenine, dolichol, coenzyme Q, heme A and prenylated proteins are also
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produced from mevalonate (Goldstein and Brown, 1 990).

Squalestatin, also called

zaragozic acid A, is a competitive inhibitor of squalene synthase at picomolar
concentrations and effectively lowers serum cholesterol in marmosets (Baxter et al,
1 992).

Squalene synthase catalyzes the committed step of cholesterol biosynthesis

(Bruenger and Rilling, 1 986). This step is the first on the pathway to cholesterol after it
branches to the various non-sterol products mentioned above.

Therefore inhibition of

squalene synthase by squalestatin selectively lowers only sterol end products, but does
Sterol and non-sterol products

not deprive the cell of important non-sterol products.

regulate the expression of proteins invo lved in cholesterol homeostasis at multiple levels
including transcription, translation and protein degradation.

In general, sterols regulate

gene expression at the level of transcription, while non-sterols act at the level of
translat ion.
Mevalonate has been shown to

decrease

HMGCoAR transcription

rates

(Goldstein and B rown, 1 990) and both CEH (Ghosh et al, 1 997; manuscript submitted)
and HMGCoAR steady-state mRNA levels (Goldstein and Brown, 1 990). In primary rat
hepatocytes cultured in serum-free medium, squalestatin decreased C7H specific activity
to

undetectable

levels

and

also

decreased

its

steady-state

mRNA

levels

and

transcriptional activity (Kinchel et al, 1 995). In the present study, mevalonate decreased
CEH promoter activity by 57% for the smallest construct, p-226Luc and it also decreased
the activity of p- 1 1 90Luc by 84% in HepG2 cells.

In contrast, treatment w ith

squalestatin along with mevalonate, restored the promoter activity of p-226Luc.
Therefore fu nctional sterol responsive sequences must be present between nt-226 and nt-

37.
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Two SRE- 1 like sequences are present between nt-226 and nt-37, one being

CACCGAA C which has a 7/8 base match and the other being CACCGATC which has a
6/8 base match w ith the consensus SRE- 1 sequence CACC(C/G)( C/T)AC, found in the
promoters of HMGCoAS , HMGCoAR and the LDLR genes (Smith et al, 1 988).

In

primary rat hepatocytes, mevalonate decreased CEH promoter activity of p- 1 3 1 7Luc to
49% of control and that of p-226Luc to 74%.

However, treatment with squalestatin,

along w ith mevalonate, only restored the promoter activity of p-226Luc. Therefore the
two SRE- 1 elements identified with HepG2 cells, also appear functional in primary rat
hepatocytes.
Thus, the CEH gene appears to have functional sterol responsive elements similar
to those of LDLR, HMGCoAS, HMGCoAR, farnesyl diphosphate synthase, squalene
syntahse, fatty acid synthase and acetyl CoA carboxylase. These genes not only have
sterol responsive elements but also different positive promoter elements that are required
for the S RE ' s to function. In the LDLR gene, the SRE- 1 is a conditional positive element
that enhances transcription in the absence of sterols, but not when they are present. The
S RE- 1 synergizes w ith two nearby sequences that are relatively weak binding sites for
the positive transcription factor SP I (Dawson et al, 1 988). In vivo, The SRE- 1 and the
two S P 1 sequences are all necessary for high level transcription in the absence of sterols.
In the HMGCoAR promoter, the SRE- 1 sequences actively repress transcription in the
presence of sterols. The SRE- 1 sequences are located in the midst of a cluster of e ight
protein binding sites, six of which bind proteins belonging to a family of transcription
factors designated the CTF and the NF- I group (NF- I , nuclear factor- ! ; CTF, CCAAT-
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binding transcription factor) (Gil et al, 1 988; Gil et al, 1 988a; Santoro et al, 1 988). The
CEH promoter has potentially both SP l and NF-Y binding sites at nt- 1 04 and nt- 1 46
respectively, that may be required for the functioning of the SRE .
The simp lest interpretation o f the data suggests the presence of a conditional
negative e lement in the proximal 226 bases of the CEH promoter.

In the presence of

sterols, the elements may bind a negative transcription factor (SREBP) that competes for
binding w ith the positive transcription factors and thus down-regulates transcription.
Nevertheless, in order to determine if these octanucleotides are true sterol regulatory
elements, it will be necessary to disrupt these elements by site-directed mutagenesis and
then test transcription levels in the presence or absence of sterols.
The region between nt- 1 1 90 and nt-859 in the case of HepG2 cells, and the region
between nt- 1 3 1 7 and nt- 1 1 90 in the case of primary rat hepatocytes, considerably
reduced promoter activity in the presence of mevalonate and the activity was not restored
to control levels by simultaneous treatment with squalestatin.

It is possible that this

region has a cis-acting element that responds to non-sterols in the cell. The existence of a
non-sterol response e lement and its ability to down-regulate transcription is u n ique and
contrary to the w idel y held view that non-sterols only act at the post-translational level.
Identification of the nature of the non-sterol, the non-sterol response element and its
putative DNA binding proteins will enable us to elucidate this novel mechanism of
regulation.
In this study the rat CEH promoter was characterized by transient transfect ion
assays in two different cell l ines. One of the aims of this study was to determine if the
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culture systems used had different effects on the CEH promoter.

The basal CEH

promoter activity in the human HepG2 cells was similar to that observed in primary rat
hepatocytes. In the presence of dexamethasone, GRE's in the CEH promotor were
mapped between nt- 1 3 1 7 and nt- 1 1 90 and between nt- 859 and nt-540 by transient
transfection assays in human HepG2 cells.

However the GRE' s mapped by transient

transfection assays in primary rat hepatocytes were located between nt- 1 1 90 to nt-859,
nt-540 to nt-4 1 8, and between nt-226 to nt-37. The glucocorticoid response sequences
mapped in these regions were the same, suggesting that the nature of the transcription
factor invo l ved, in this case the glucocorticoid receptor, could account for the differences
observed in the location of the glucocorticoid response regions.

Alternatively, the

interaction between the transcription factor and the transcript ion initiation complex could
also influence the rate of transcription of the gene. This, in turn, would depend on the
nature of the transactivating domain of the transcription factor and its proximity to the
transcription init iation complex.
phosphorylates other proteins.

Phorbol esters are activators of PKC, which in turn
As mentioned earlier, phosphorylation events are post-

translational modifications that affect the activity of DNA binding proteins in different
ways. Thus depending on the nature of the phosphorylation event, transcription factors
can be turned "on" or turned "off'. The kinases involved could also be different in the
two cell J ines and this in turn could account for the differential effects observed in the
two cu lture systems.

Final ly the SRE identified by transient transfection assays in the

two cel l lines were exactly identical, suggesting that the transcription factor/s that
respond to the level of sterols in the two cell lines are similar. Thus it appears that a more
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detailed and specific study would be required to detect differences between a homologous
culture system and a heterologous culture system.
It is apparent that coordinate regulation of fatty acid and cholesterol metabo lism is
essential for balanced membrane biosynthesis and turnover, to accommodate metabolic
fluctuations that occur during normal cellular growth.

Moreover, these two important

l ip ids are simu ltaneously required in the liver for regular, ordered assembly of very low
density l ipoprotein particles, which deliver their lipid load of cholesterol and fatty acids
fro m the l iver to other sites in the body to maintain lipid homeostasis (Brown and
Goldstein, 1 986) . Therefore, not surprisingly, the genes in these pathways are also
apparently co-regulated. They share common cis-acting elements and specific regulatory
proteins that bind to these elements in order to coordinately regulate the expression of
these genes.

An example of such a regulatory sequence is the sterol response element

(SRE- 1 ). As mentioned before, SRE- 1 sequences have been found in the promoters of
genes that regulate cholesterol metabolism l ike LDLR, HMGCoAR, HMGCoAS, and
squalene synthase.

Moreover, these SRE- 1 sequences have also been identified in the

promoters of genes that regulate fatty acid metabo lism like fatty acid synthase, an
essential enzyme of fatty acid biosynthesis, acetyl coenzyme A carboxylase, the ratecontro lling enzyme for fatty acid biosynthesis, and hormone sensitive lipase, an enzyme
that plays a key role in adipocyte lipid metabolism. SREBP- 1 is the regulatory protein
that binds to the S RE- 1 sequence in humans. The rat equivalent of SREBP- 1 was cloned
fro m an adipocyte cDN A expression library (Tontonoz et al. 1 993).

The rat SREBP

mRNA was induced during adipocyte differentiation in cell culture, and so it was named
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the adipocyte determination- and different iation- dependent factor (ADD 1 ).

SREBP- 1

binds to the SRE- 1 sequence in the promoters of genes involved in cholesterol
metabo lism and regulates cellu lar sterol levels. Moreover, expression of the mRNA ' s for
fatty acid synthase and acetyl coenzyme A carboxylase have been demonstrated to be
regulated by sterols in a manner similar to genes that encode proteins of cholesterol
metabo lism and ADD 1 is the regulatory protein implicated in the sterol responsiveness of
these genes. S ince ADD 1 is the rat equivalent of SREBP- 1 , it is evident that SREBP1 /ADD 1 serves as a direct molecular connection between the regulation of two different
classes of cellular lipids that are both required for cellular growth and normal lipoprotein
metabolism.
As mentioned before, CEH hydrolyzes cholesteryl esters to cholesterol and free
fatty acids. This enzyme is therefore uniquely capable of regulating this aspect of both
cho lesterol and fatty acid metabolism.

In this study we have identified and mapped

functional S RE- 1 sequences in the 5' flanking portion of the rat CEH gene, to which
S REBP- 1 or ADD 1 could bind.

Presence of these functional SRE- 1 sequences in the

CEH promoters indicates the importance of this enzyme in regulation of cholesterol
metabolism. Previously, CEH has been shown to hydrolyze a broad range of substrates
(Natarajan et al, 1 996a) including cholesteryl esters and triglycerides.

In the current

study we also demonstrated the presence of functional hormone response elements.
These hormone response elements have been previously ident ified in the promoters of
genes that regulate fatty acid metabo lism.

Therefore, considering the ability of this

enzyme to release free fatty acids from different substrates, and the presence of various

94
hormone response elements in the CEH promoter, similar to those present in the
promoters of genes that regulate fatty acid metabo lism, it is apparent that this enzyme
could also play a significant role in fatty acid metabolism.
Thus, while coordinate regulation can be mediated by the involvement of SREBPI /ADD I in the transcriptional control of fatty acid synthesis and cholesterol homeostasis,
the abi lity of CEH to release both cho lesterol and fatty acids, the broad substrate
specificity of this enzyme, and the presence of functional sterol response elements and
hormone response elements in its promoter makes this enzyme a candidate for an
additional level of coordinate regulation, which in turn could link the two pathways
together.
In this dissertation the isolation and regulation of the rat hepatic neutral CEH
promoter by various physiological stimuli has been described.

It appears that the rat

CEH gene is regulated by mult iple physiological stimuli that fine tune the expression of
the gene. Moreover, due to overlapping consensus sequences in the proximal 226 bases,
compet ition for binding by transcription factors and their cross talk would eventually
determine the level of CEH expression.

Finally, determination of exact cis-acting

sequences and the transcription factors that bind to them would enable us to have a
greater understanding of the transcriptional regulation of the CEH gene.
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